EP2081543A2 - Agents d'éclaircissement contenant une ou plusieurs pipéridones et imidazoles - Google Patents

Agents d'éclaircissement contenant une ou plusieurs pipéridones et imidazoles

Info

Publication number
EP2081543A2
EP2081543A2 EP07847729A EP07847729A EP2081543A2 EP 2081543 A2 EP2081543 A2 EP 2081543A2 EP 07847729 A EP07847729 A EP 07847729A EP 07847729 A EP07847729 A EP 07847729A EP 2081543 A2 EP2081543 A2 EP 2081543A2
Authority
EP
European Patent Office
Prior art keywords
group
methyl
amino
acid
oxopiperidinium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07847729A
Other languages
German (de)
English (en)
Inventor
Wibke Gross
Georg KNÜBEL
Ralph Nemitz
Kristin Pauli
Denise Fuhr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP2081543A2 publication Critical patent/EP2081543A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/08—Preparations for bleaching the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles

Definitions

  • the present invention relates to agents for lightening keratinic fibers, i. Agent for use on keratin fibers, in particular human hair, and their use.
  • Coupler and developer components are also referred to as oxidation dye precursors.
  • hair dyeing and / or lightening agents are mixed in solid or pasty form with dilute aqueous hydrogen peroxide solution. This mixture is then applied to the hair and rinsed again after a certain exposure time. The duration of exposure to the hair to achieve complete coloration or lightening is between about 30 and 40 minutes. It is obvious that there is a need among users of these hair dyes or bleaching agents to reduce this exposure time. Neither the pasty nor the powdered dyeing and / or bleaching agents that are on the market today can be considered optimal. While the dyeing and / or bleaching effect on the hair may be said to be tailored to consumer needs, there are still a number of disadvantages and problems both in the manufacture and handling of these agents.
  • bleaching processes on keratinic fibers usually proceed at alkaline pH values, in particular between 9.0 and 10.5. These pH values are necessary to ensure an opening of the outer cuticle (cuticle) and to allow a penetration of the active species (dye precursors and / or hydrogen peroxide) into the hair.
  • the alkalizing agent used is usually ammonia, which however has the disadvantage of intense odor and possible irritation for the users.
  • aminomethylpropanol or monoethanolamine are used as alternative alkalizing agents to ammonia.
  • they are usually used in admixture with ammonia. But even here, the performance of the ammonia is impaired, especially with regard to the parameters gray covering, whitening performance and color result.
  • Object of the present invention was to provide novel means for whitening or bleaching hair, which are comparable or superior in their Advicehellmaschine the usual on the market funds, but at the same time have a reduced hair damage.
  • the invention relates, in a first embodiment, to an agent for whitening keratin fibers, in particular human hairs, containing - in each case based on its weight - a) 0.1-4.9% by weight of at least one oxopiperidinium derivative of the general structure (I)
  • R1 and R2 independently represent a dC 6 alkyl group, a C 2 -C 6 - alkenyl group, an aryl C- ⁇ -C6 alkyl group, a C 2 -C 6 hydroxyalkyl group, a C 2 -C 6 - polyhydroxyalkyl or dC 6 alkoxy-C2-C6 alkyl group
  • X represents a physiologically acceptable anion, said anion is preferably selected from chloride, bromide or iodide, p-toluenesulfonate, benzenesulfonate, methyl sulfate, / 4 sulfate, hydrogen sulfate, acetate , Methanesulfonat or trifluoromethanesulfonate, b) 0.1 to 4.0 wt .-% of at least one imidazole compound according to formula (II) and / or their physiologically acceptable salts
  • R 1 represents a hydrogen atom, an optionally substituted aryl group or a (C 1 -C 6 ) -alkyl group,
  • R 2 represents a hydrogen atom, a carboxaldehyde group, a (C 1 -C 6 ) -alkyl group or a nitro group
  • R 3 is a hydrogen atom, a carboxy (C 1 -C 6 ) -alkyl group, an AmJnO- (C 1 -C 6 ) -alkyl group, a carboxyl group, a carboxaldehyde group, a (C 1 -C 6 ) - Alkyl group, a nitro group, a 2-amino-3-hydroxypropyl group or a group -CH 2 -CH (NH 2 ) - COOH,
  • R 4 represents a hydrogen atom, a carboxaldehyde group or a carboxyl group, c) 0.1-12.0% by weight of hydrogen peroxide (calculated as 100% H 2 O 2 ).
  • Keratin fibers mean furs, wool, feathers and in particular human hair. Although the compositions according to the invention are primarily suitable for dyeing and / or whitening keratin fibers, in principle, there is nothing to prevent their use in other fields as well.
  • compositions according to the invention contain at least three essential constituents: at least one oxopiperidinium derivative of the formula (I), at least one imidazole compound of the formula (II) and hydrogen peroxide.
  • Compositions according to the invention may also be "application mixtures", i.e. agents which, although present in separate packages (for example for reasons of stability), are mixed with one another before application into an application mixture and then applied.
  • compositions according to the invention contain, based on their weight, 0.1-4.9% by weight of at least one oxopiperidinium derivative of the general structure (I)
  • R1 and R2 independently of one another represent a dC 6 alkyl group, a C 2 -C 6 alkyl group alkenyl group, an aryl C- ⁇ -C 6, a C 2 -C 6 hydroxyalkyl group, a C 2 -C 6 Polyhydroxyalkyl distr or a dC 6 alkoxy-C2-C6-alkyl group and
  • X is a physiologically acceptable anion, said anion is preferably selected from chloride, bromide or iodide, p-toluenesulfonate, benzenesulfonate, methyl sulfate, / 4 sulfate, hydrogen sulfate , Acetate, methanesulfonate or trifluoromethanesulfonate.
  • radicals a dC 6 alkyl group R1 and R2 is independently (especially a methyl group or an ethyl group), a C 2 -C 6 alkenyl group (especially allyl) or an aryl dC 6 alkyl group (particularly, a Benzyl group). It is particularly preferred if both radicals R 1 and R 2 represent a methyl group.
  • the counterion X ' is a halide ion (in particular bromide), Vi sulfate, hydrogen sulfate or p-toluenesulfonate.
  • agents according to the invention contain, as the oxopiperidinium derivative of the general structure (I), at least one compound from the group consisting of 1, 1-dimethyl-4-oxopiperidinium p-toluenesulfonate, 1,1-dimethyl-4-oxopiperidinium methylsulfonate, 1,1-dinethyl-4-oxopiperidiniunnonium chloride, 1,1-dimethyl-4-oxopiperidinium hydrogensulfate, 1,1-dimethyl-4-oxopiperidinediamine-n-methylsulfate, 1, 1-Dimethyl-4-oxopiperidiniunnate acetate, 1-ethyl-1-methyl-4-oxopiperidine-p-toluenesulfonate, 1-ethyl-1-methyl-4-oxopiperidine-dimethylsulfonate, 1-ethyl-1-methyl-4- oxopiperidinium-bronnide, 1-ethyl-1-methyl
  • the oxopiperidinium derivative (s) of formula (I) are used within narrower ranges.
  • Agents according to the invention are preferred here which, based on their weight, contain from 0.2 to 4.0% by weight, preferably from 0.5 to 3.5% by weight, particularly preferably from 0.75 to 3.0% by weight. % and in particular 1, 0 to 2.5 wt .-% of at least one Oxopiperidiniumderivates the general structure (I).
  • the agents according to the invention contain from 0.1 to 4.0% by weight of at least one imidazole compound of the formula (II) and / or physiologically acceptable salts thereof in the
  • R 1 represents a hydrogen atom, an optionally substituted aryl group or a (C 1 -C 6 ) -alkyl group,
  • R 2 represents a hydrogen atom, a carboxaldehyde group, a (C 1 -C 6 ) -alkyl group or a nitro group,
  • R 3 represents a hydrogen atom, a carboxy (C 1 -C 6 ) -alkyl group, an AmJnO- (C 1 -C 6 ) -alkyl group, a carboxyl group, a carboxaldehyde group, a (C 1 -C 6 ) -alkyl group , a nitro group, a 2-amino-3-hydroxypropyl group or a group -CH 2 -CH (NH 2 ) -COOH,
  • R 4 represents a hydrogen atom, a carboxaldehyde group or a carboxyl group.
  • the imidazole compound (s) of formula (II) are / are used within narrower ranges.
  • Preferred agents according to the invention are those which contain from 0.2 to 3.5% by weight, preferably from 0.5 to 3.0% by weight, more preferably from 0.75 to 2.75% by weight and in particular from 1.0 to 2.5 wt .-% of at least one imidazole of the formula (II).
  • the imidazole compounds of formula (II) are selected from at least one member of a group formed from histamine, D-histidine, L-histidine, DL-histidine, D-histidinol, L-histidinol, DL-histidinol, imidazole , imidazole-4-acetic acid, imidazole-4-carboxylic acid, imidazole-4,5-dicarboxylic acid, imidazole-2-carboxaldehyde, imidazole-4-carboxaldehyde, imidazole-5-carboxaldehyde, 2-nitroimidazole, 4-nitroimidazole, 4-methylimidazole 5-carboxaldehyde, N-methylimidazole-2-carboxaldehyde, 4-methylimidazole, 2-methylimidazole, N-methylimidazole, N- (4-aminophenyl) -imidazole, and the physiologically acceptable
  • Imidazole is particularly preferably used according to the invention. Accordingly, preferred agents according to the invention are characterized in that the imidazole compound according to formula (I) and / or its physiologically tolerable salts is / are selected from histamine, D-histidine, L-histidine, DL-histidine, D-histidinol, L-histidinol, DL-histidinol, imidazole, imidazole-4-acetic acid, imidazole-4-carboxylic acid, imidazole-4,5-dicarboxylic acid, imidazole-2-carboxaldehyde, imidazole-4-carboxaldehyde, imidazole-5-carboxaldehyde, 2-nitroimidazole, 4- Nitroimidazole, 4- Methylimidazole-5-carboxaldehyde, N-methylimidazole-2-carboxaldehyde, 4-methylimidazole, 2-methylimidazo
  • the main body of the formula (II), the imidazole is particularly preferred.
  • the compositions according to the invention contain 0.1-12.0% by weight of hydrogen peroxide (calculated as 100% H 2 O 2 ).
  • hydrogen peroxide itself is used as the aqueous solution.
  • the hydrogen peroxide can also be used in the form of a solid addition compound of hydrogen peroxide to inorganic or organic compounds such as sodium perborate, sodium percarbonate, magnesium percarbonate, sodium percarbamide, polyvinylpyrrolidone n H 2 O 2 (n is a positive integer greater than 0), urea peroxide and melamine peroxide become.
  • aqueous hydrogen peroxide solutions are aqueous hydrogen peroxide solutions.
  • concentration of a hydrogen peroxide solution is determined on the one hand by the legal requirements and on the other hand by the desired effect; preferably 6-12% solutions in water are used.
  • Agents preferred according to the invention are characterized in that they contain, based on their weight, from 1 to 11% by weight, preferably from 2 to 10% by weight, particularly preferably from 3 to 9% by weight, more preferably from 4 to 8% by weight. % and in particular 5 to 7 wt .-% hydrogen peroxide (calculated as 100% H 2 O 2 ) included.
  • the agents according to the invention optionally contain ammonia (calculated as 100% NH 3 ), the amount of which is preferably limited to a maximum of 3% by weight, based on the total agent or, in the case of multi-component agents, of the ready-to-use mixture.
  • Preferred agents or application mixtures according to the invention contain less than 2% by weight, preferably less than 1.5% by weight, more preferably less than 1% by weight and in particular less than 0.5% by weight of ammonia (calculated as 100% NH 3 ), with preferred agents being free of ammonia.
  • At least one further bleach booster is preferably used in the cosmetic compositions according to the invention.
  • Bleach boosters are preferably used to increase the bleaching action of the oxidizing agent, in particular the hydrogen peroxide. Suitable bleach boosters are
  • (BV-i) compounds which give aliphatic peroxycarboxylic acids and / or optionally substituted perbenzoic acid under perhydrolysis conditions, and / or
  • bleach amplifiers it is possible to use compounds which, under perhydrolysis conditions, give aliphatic peroxycarboxylic acids having preferably 1 to 10 C atoms, in particular 2 to 4 C atoms, and / or optionally substituted perbenzoic acid.
  • Suitable substances are those which carry oxygen- and / or nitrogen-bonded acyl groups with the stated number of carbon atoms and / or optionally substituted benzoyl groups.
  • polyacylated alkylenediamines in particular tetraacetylethylenediamine (TAED), acylated triazine derivatives, in particular 1,5-diacetyl-2,4-dioxohexahydro-1,3,5-triazine (DADHT), acylated glycolurils, in particular tetraacetylglycoluril (TAGU), N- Acylimides, in particular N-nonanoyl-succinimide (NOSI), acylated phenolsulfonates, in particular n-nonanoyl or isononanoyloxybenzenesulfonate (n- or iso-NOBS), carboxylic anhydrides, in particular phthalic anhydride, acylated polyhydric alcohols, in particular triacetin, ethylene glycol diacetate and 2,5- diacetoxy-2,5-dihydrofuran.
  • TAED tetraacet
  • the carbonate or bicarbonate salts are preferably selected from at least one compound of the group consisting of ammonium, alkali (especially sodium and potassium), and alkaline earth (especially calcium), carbonate salts and bicarbonate salts.
  • Particularly preferred carbonate or bicarbonate salts are ammonium bicarbonate, ammonium carbonate, sodium bicarbonate, disodium carbonate, potassium bicarbonate, dipotassium carbonate and calcium carbonate. These particularly preferred salts can be used alone or in their mixtures of at least two representatives as bleaching amplifiers.
  • Preferably usable organic carbonates are selected from at least one compound of the group of carbonic acid monoesters and / or from at least one compound of the group of carbonic acid monoamides.
  • carbonic acid monoesters are the carbonic acid monoesters of the formula (BV-1),
  • R-O-C-OH O (BV-1) in which R is a saturated or unsaturated, straight-chain, branched, or cyclic, substituted or unsubstituted hydrocarbon radical, or a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocycle.
  • R preferably represents a substituted or unsubstituted, straight-chain or branched alkyl, alkenyl or alkynyl radical, preference being given to hydroxy, amino, nitro, sulfonic acid groups or halogens as substituents.
  • Further preferred radicals R are phenyl and benzyl radicals and further substituted representatives. More preferably, R is a Ci_ 6 alkyl group.
  • C 1 -C 6 -alkyl groups are the groups methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, pentyl, isopentyl and hexyl.
  • compositions particularly preferably used according to the invention are characterized in that the radical R in formula (BV-1) is selected from methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert Butyl and hydroxymethyl and hydroxyethyl radicals.
  • Preferred carbonic acid monoamides are the compounds of the formula (BV-2),
  • R is a saturated or unsaturated, straight-chain, branched, or cyclic, substituted or unsubstituted hydrocarbon radical, or a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocycle.
  • R preferably represents a substituted or unsubstituted, straight-chain or branched alkyl, alkenyl or alkynyl radical, preference being given to hydroxy, Amino, nitro, sulfonic acid groups or halogens come into question.
  • Further preferred radicals R are phenyl and benzyl radicals and further substituted representatives. More preferably, R is a Ci_ 6 alkyl group.
  • C 1 -C 6 -alkyl groups are the groups methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, pentyl, isopentyl and hexyl.
  • Particularly preferred bleaching enhancers of the formula (BV-2) according to the invention are characterized in that the radical R in formula (BV-2) is selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, Iso-butyl, tert-butyl and hydroxymethyl and hydroxyethyl radicals.
  • the acidic H atom of the carbonic acid monoester or monoamide may also be in neutralized form, i. salts of carbonic acid monoesters or carbonic acid monoamides can also be used according to the invention.
  • At least one compound selected from the group consisting of acetic acid, lactic acid, tartaric acid, citric acid, salicylic acid and orthophthalic acid may preferably be contained.
  • the bleach boosters are contained in the compositions according to the invention preferably in amounts of from 5 to 30% by weight, in particular in amounts of from 8 to 20% by weight, based in each case on the weight of the ready-to-use agent.
  • compositions according to the invention containing less than 2% by weight, preferably less than 1.5% by weight, particularly preferably less than 1% by weight and in particular less than 0.5% by weight of ammonium and alkali metal persulfates and peroxymonosulphates and peroxydisulphates, preferred agents being free of all the compounds mentioned, are preferred embodiments of the present invention.
  • compositions according to the invention can also be prepared directly before use from two or more separately packaged preparations. This is particularly useful for the separation of incompatible ingredients to avoid premature reaction. Therefore, a common route is to mix an agent A containing oxopiperidinium compound (s) and imidazole (s) directly before use with an oxidizer preparation B to an application mixture.
  • Another object of the present invention is therefore an agent for dyeing and / or lightening keratinic fibers, in particular human hair, which immediately before application to the hair of a flowable preparation A, an oxidizing agent preparation B containing at least one oxidizing agent selected from hydrogen peroxide and whose addition compounds to solid carriers and optionally a preparation C, which are mixed together to a dyeing and / or Friedhellanthesis is obtained, wherein the composition contains A and / or C oxopiperidinium compound (s) and imidazole (s), or the composition A.
  • Oxopiperidinium compound (s) and the preparation C contains imidazole (s) (or vice versa).
  • the mixture of formulations A, B and C prior to use results in an application mixture which is an inventive agent with the three compulsive ingredients.
  • the oxidizer formulation B is preferably an aqueous, flowable oxidizer formulation.
  • Preferred agents for lightening keratinic fibers according to the invention are characterized in that the flowable oxidizing agent preparation B - based on its weight - 40 to 90 wt .-%, preferably 50 to 85 wt .-%, particularly preferably 55 to 80 wt .-%, more preferably 60 to 77.5 wt .-% and in particular 65 to 75 wt .-% water.
  • an emulsifier or a surfactant is added to the flowable oxidizing agent preparation B, surfactants depending on the field of use being referred to as surfactants or as emulsifiers and being selected from anionic, cationic, zwitterionic, ampholytic and nonionic surfactants and emulsifiers. These substances are described in detail below.
  • the dyeing and / or brightening agents according to the invention contain nonionic surfactants.
  • These are surface-active Substances having an HLB of 5.0 and greater are preferred.
  • HLB surface-active Substances having an HLB of 5.0 and greater are preferred.
  • HLB value reference is explicitly made to the statements in Hugo Janistyn, Handbuch der Kosmetika und Riechstoffe, IM. Volume: The personal care products, 2nd edition, Dr. med. Alfred Hüthig Verlag Heidelberg, 1973, pages 68-78 and Hugo Janistyn, Paperback of modern perfumery and cosmetics, 4th edition, Scientific Verlagsgesellschaft mbH Stuttgart, 1974, pages 466-474, as well as the original works cited therein reference.
  • non-ionic surface-active substances are substances that are commercially available as solids or liquids in pure form because of their ease of processing.
  • the definition of purity in this context does not refer to chemically pure compounds. Rather, especially when it comes to natural-based products, mixtures of different homologs can be used, for example, with different alkyl chain lengths, such as those obtained with products based on natural fats and oils. Even with alkoxylated products, mixtures of different degrees of alkoxylation are usually present.
  • purity in this context refers rather to the fact that the chosen substances should preferably be free from solvents, stabilizers and other impurities.
  • Preferred nonionic surfactants are:
  • fatty alkyl groups having 8 to 22, in particular 10 to 16, carbon atoms in the fatty alkyl group and 1 to 30, in particular 1 to 15, ethylene oxide and / or propylene oxide units.
  • Preferred fatty alkyl groups are, for example, lauryl, myristyl, cetyl, but also stearyl, isostearyl and oleyl groups.
  • Particularly preferred compounds of this class are, for example, lauryl alcohol with 2 to 4 ethylene oxide units, oleyl and cetyl alcohol with 5 to 10 ethylene oxide, cetyl alcohol and stearyl alcohol and mixtures thereof with 10 to 30 ethylene oxide units and the commercial product Aethoxal ® B (Henkel), Lauryl alcohol with 5 ethylene oxide and 3 propylene oxide units.
  • the alkoxy group has no OH group at the end but is "closed” in the form of an ether, in particular a C 1 -C 4 -alkyl ether.
  • An example of such a compound is the commercially available product ® Dehypon LT 054, a C 2-18 -Fettalkoholol + 4.5 ethylene oxide-butyl ether.
  • alkoxylated fatty acids having 8 to 22, in particular 10 to 16, carbon atoms in the fatty acid group and 1 to 30, in particular 1 to 15, ethylene oxide and / or propylene oxide Units.
  • Preferred fatty acids are, for example, lauric, myristic, palmitic, stearic, isostearic and oleic acids.
  • - alkoxylated, preferably propoxylated and especially ethoxylated, mono-, di- and triglycerides examples are glycerol monolaurate + 20 ethylene oxide and glycerol monostearate + 20 ethylene oxide.
  • Polyglycerol esters and alkoxylated polyglycerol esters are for example poly (3) glycerol diisostearate (commercial product: Lamefornn ® TGI (Henkel)) and poly (2) glycerinpolyhydroxy- stearate (commercial product: Dehymuls ® PGPH (Henkel)).
  • Sorbitan fatty acid esters and alkoxylated sorbitan fatty acid esters such as sorbitan monolaurate and sorbitan monolaurate + 20 ethylene oxide (EO).
  • Alkylphenols and Alkylphenolalkoxylate having 6 to 21, in particular 6 to 15, carbon atoms in the alkyl chain and 0 to 30 ethylene oxide and / or propylene oxide units.
  • Preferred representatives of this class are, for example, nonylphenol + 4 EO, nonylphenol + 9 EO, octylphenol + 3 EO and octylphenol + 8 EO.
  • nonionic surfactants are the alkoxylated fatty alcohols, the alkoxylated fatty acids and the alkylphenols and alkylphenol alkoxylates.
  • Agents according to the invention which contain non-ionic surface-active substances in amounts of 1 to 5% by weight have proved to be particularly advantageous.
  • the dyeing and / or brightening agents according to the invention may contain all known in such preparations active ingredients, additives and excipients.
  • the agents contain at least one surfactant, wherein in principle both anionic and zwitterionic, ampholytic, nonionic and cationic surfactants are suitable.
  • anionic surfactants may be very particularly preferred.
  • Preferred anionic surfactants are alkyl sulfates, ether carboxylic acid salts having 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule such as C 12 H 25 - (C 2 H 4 O) 6 -CH 2 -COONa and in particular salts of saturated and especially unsaturated C8-C22 carboxylic acids such as oleic acid, stearic acid, isostearic acid and palmitic acid.
  • anionic surfactants should preferably be present in solid, in particular powder form. Very particular preference is given to solid soaps, especially sodium stearate, at room temperature. These are preferably present in amounts of from 5 to 20% by weight, in particular from 10 to 15% by weight.
  • Suitable nonionic surfactants are in particular C 8 -C 22 -alkyl mono- and oligoglycosides and their ethoxylated analogs.
  • the nonethoxylated compounds have been found to be particularly suitable.
  • ammonium halides such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkyl methylammonium chlorides, eg. Cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride.
  • Further cationic surfactants which can be used according to the invention are the quaternized protein hydrolysates.
  • Alkylamidoamines in particular fatty acid amidoamines, such as the stearylamidopropyldimethylamine obtainable under the name Tego Amid® S 18, are distinguished not only by a good conditioning action but also by their good biodegradability.
  • esterquats such as the Distearoylethylhydroxyethylammoniummethosulfat available as a mixture with cetearyl under the name Dehyquart® ® F 75 miles.
  • the compounds containing alkyl groups used as surfactants may each be uniform substances. However, it is usually preferred in the manufacture of these substances native vegetable or animal raw materials, so that one obtains substance mixtures with different, depending on the particular raw material alkyl chain lengths.
  • nonionic polymers such as vinyl pyrrolidone / vinyl acrylate copolymers
  • anionic polymers such as polyacrylic acids, crosslinked polyacrylic acids and
  • Vinyl acetate / crotonic acid copolymers provided that they are stable as solids or preferably in
  • Thickeners such as agar-agar, guar gum, alginates, xanthan gum, gum arabic,
  • Derivatives such as amylose, amylopectin and dextrins, clays such. B. bentonite or fully synthetic
  • Hydrocolloids such as e.g. polyvinyl alcohol,
  • Structurants such as glucose, maleic acid and lactic acid, hair conditioning compounds such as phospholipids, for example, soybean lecithin, egg lecithin and cephalins, and silicone oils
  • Protein hydrolysates in particular elastin, collagen, keratin, milk protein, soy protein and
  • Active ingredients such as panthenol, pantothenic acid, allantoin, pyrrolidonecarboxylic acids and their
  • Fats and waxes such as spermaceti, beeswax, montan wax, paraffins,
  • Swelling and penetration substances such as carbonates, bicarbonates, guanidines, ureas and primary, secondary and tertiary phosphates,
  • compositions according to the invention may contain at least one ammonium compound from the group consisting of ammonium chloride, ammonium carbonate, ammonium bicarbonate, ammonium sulfate and / or ammonium carbamate in an amount of from 0.5 to 10, preferably from 1 to 5,% by weight, based on the total composition of the composition ,
  • dyeing and / or brightening agents according to the invention may contain further active ingredients, auxiliaries and
  • Additives such as nonionic polymers such as vinylpyrrolidone / vinyl acrylate copolymers,
  • Dimethyldiallylammonium chloride polymers acrylamide-dimethyldiallyl-ammonium chloride
  • Copolymers vinylpyrrolidone-imidazolinium methochloride copolymers and quaternized polyvinyl alcohol, zwitterionic and amphoteric polymers such as, for example, acrylamidopropyltrimethylammonium chloride / acrylate copolymers and octylacrylamide / methyl methacrylate / tert.
  • Butylaminoethyl methacrylate ⁇ -hydroxypropyl methacrylate copolymers anionic polymers such as polyacrylic acids, crosslinked polyacrylic acids,
  • Thickeners such as agar-agar, guar gum, alginates, xanthan gum, gum arabic, karaya
  • Protein hydrolysates in particular elastin, collagen, keratin, milk protein, soy protein and
  • Solvents and mediators such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerol and diethylene glycol, fiber-structure-improving agents, especially mono-, di- and oligosaccharides such as glucose, galactose, fructose, fructose and lactose, quaternized amines such as methyl-1-alkylamidoethyl-2 -alkylimidazolinium methosulfate
  • Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,
  • Light stabilizers in particular derivatized benzophenones, cinnamic acid derivatives and triazines,
  • Active ingredients such as allantoin, pyrrolidonecarboxylic acids and their salts, and bisabolol,
  • Vitamins, provitamins and vitamin precursors in particular those of groups A, B 3 , B 5 , B 6 , C,
  • Plant extracts such as extracts of green tea, oak bark, stinging nettle, witch hazel,
  • Spruce needle horse chestnut, sandalwood, juniper, coconut, mango, apricot, lime,
  • Ginger root Ginger root ,.
  • Bodying agents such as sugar esters, polyol esters or polyol alkyl ethers,
  • Fats and waxes such as spermaceti, beeswax, montan wax and paraffins,
  • Swelling and penetration substances such as glycerol, propylene glycol monoethyl ether, carbonates,
  • Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
  • Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate, pigments,
  • Stabilizers for hydrogen peroxide and other oxidizing agents include propellants such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air, antioxidants
  • compositions according to the invention may contain the ingredients in a suitable aqueous, alcoholic or aqueous-alcoholic carrier.
  • a suitable aqueous, alcoholic or aqueous-alcoholic carrier for the purpose of hair coloring such carriers are, for example, creams, emulsions, gels or surfactant-containing foaming solutions, such as shampoos, foam aerosols or other preparations which are suitable for use on the hair.
  • a powdered or tablet-shaped formulation which is preferred for dyeing and / or brightening agents.
  • aqueous-alcoholic solutions are to be understood as meaning aqueous solutions containing from 3 to 70% by weight of a C 1 -C 4 -alkoHoI, in particular ethanol or isopropanol.
  • the compositions of the invention may additionally contain other organic solvents, such as methoxybutanol, benzyl alcohol, ethyl diglycol or 1, 2-propylene glycol. Preference is given to all water-soluble organic solvents.
  • Preferred agents according to the invention are characterized in that they additionally contain a nonaqueous solvent, particularly preferred compositions according to the invention the solvent in a concentration of 0.1 to 30 weight percent, preferably in a concentration of 1 to 20 weight percent, most preferably in a concentration of 2 - 10 weight percent, each based on the agent included.
  • the solvent is selected from ethanol, n-propanol, isoropanol, n-butanol, propylene glycol, n-butylene glycol, glycerol, diethylene glycol monoethyl ether, diethylene glycol mono-n-butyl ether, phenoxyethanol and benzyl alcohol and mixtures thereof.
  • the pH of the compositions according to the invention can be adjusted within a wide range by suitable ingredients such as acidifying agent or alkalizing agent.
  • agents according to the invention may also contain dyes and / or dye precursors and thus act as agents which at the same time have a brightening and coloring effect.
  • dyes and / or dye precursors Such agents will hereinafter be referred to as “colorants”, as “whitening colorants” or as “colorants and whiteners”.
  • Oxidative dyeing of the fibers can in principle be carried out with atmospheric oxygen in the presence of oxidation dye precursors.
  • a chemical oxidizing agent is used, especially if, in addition to the coloring, a lightening effect on human hair is desired. This lightening effect may be desired regardless of the staining method.
  • the presence of oxidation dye precursors is not a mandatory requirement for the use of oxidizing agents in the compositions according to the invention.
  • Suitable oxidizing agents are persulfates, chlorites and in particular hydrogen peroxide or its addition products of urea, melamine and sodium borate.
  • the oxidation colorant can also be applied to the hair together with a catalyst which promotes the oxidation of the dye precursors, e.g. by atmospheric oxygen, activated.
  • catalysts are e.g. Metal ions, iodides, quinones or certain enzymes.
  • Suitable metal ions are, for example, Zn 2+ , Cu 2+ , Fe 2+ , Fe 3+ , Mn 2+ , Mn 4+ , Li + , Mg 2+ , Ca 2+ and Al 3+ . Particularly suitable are Zn 2+ , Cu 2+ and Mn 2+ .
  • the metal ions can in principle be used in the form of any physiologically acceptable salt or in the form of a complex compound.
  • Preferred salts are the acetates, sulfates, halides, lactates and tartrates.
  • Suitable enzymes include peroxidases, which can significantly enhance the effect of small amounts of hydrogen peroxide. Furthermore, such enzymes are suitable according to the invention which directly oxidize the oxidation dye precursors with the aid of atmospheric oxygen, such as, for example, the laccases, or generate small amounts of hydrogen peroxide in situ and thus biocatalytically activate the oxidation of the dye precursors. Particularly suitable catalysts for the oxidation of the dye precursors are the so-called 2-electron oxidoreductases in combination with the specific substrates, eg
  • Pyruvate oxidase and pyruvic acid or its salts - alcohol oxidase and alcohol (MeOH, EtOH), lactate oxidase and lactic acid and its salts, tyrosinase oxidase and tyrosine, uricase and uric acid or their salts, choline oxidase and choline, amino acid oxidase and amino acids.
  • the actual brightening and / or coloring agent is expediently prepared immediately before use by mixing the preparation of the oxidizing agent with the preparation comprising the compounds of the formula (I) and of the formula (II) and, if appropriate, dye precursors.
  • the resulting ready-to-use whitening and / or hair-dyeing preparation should preferably have a pH in the range of 6 to 12. Particularly preferred is the use of brightening and / or hair dyeing in a weakly alkaline medium.
  • the application temperatures can be in a range between 15 and 40 0 C.
  • the hair dye is removed by rinsing of the hair to be dyed.
  • the washing with a shampoo is omitted if a strong surfactant-containing carrier, such as a dyeing shampoo was used.
  • an agent according to the invention may optionally be applied to the hair with additional dye precursors but also without prior mixing with the oxidation component. After an exposure time of 20 to 30 minutes, the oxidation component is then applied, if appropriate after an intermediate rinse. After a further exposure time of 10 to 20 minutes, the product is then rinsed and, if desired, shampooed again.
  • the corresponding agent is adjusted to a pH of about 4 to 7.
  • an air oxidation is initially desired, wherein the applied agent preferably has a pH of 7 to 10.
  • the use of acidified peroxydisulfate solutions may be preferred as the oxidizing agent.
  • compositions according to the invention may contain further ingredients.
  • use of certain metal ions or complexes may be preferred to obtain intense colorations.
  • Agents according to the invention which additionally contain Cu, Fe, Mn, Ru ions or complexes of these ions are preferred here.
  • Preferred agents according to the invention additionally contain Cu, Fe, Mn, Co, Ce, V, Ru ions or complexes of these ions, with particularly preferred agents being 0.0001 to 2.5% by weight, preferably 0.001 to 1 wt .-% of at least one compound from the group copper chloride (CuCl 2 ), copper sulfate (CuSO 4 ), iron (II) sulfate, manganese (II) sulfate, manganese (II) chloride, cobalt (II) chloride, cerium sulfate, cerium chloride , Vanadium sulfate, manganese dioxide (MnO 2 ).
  • CuCl 2 copper chloride
  • CuSO 4 copper sulfate
  • iron (II) sulfate iron
  • manganese (II) sulfate manganese (II) chloride
  • cobalt (II) chloride cerium sulfate, cerium chloride , Vanadium
  • Complex images are substances that can complex metal ions.
  • Preferred complexing agents are so-called chelate complexing agents, ie substances which form cyclic compounds with metal ions, a single ligand occupying more than one coordination site on a central atom, i. H. at least "bidentate".
  • chelate complexing agents ie substances which form cyclic compounds with metal ions, a single ligand occupying more than one coordination site on a central atom, i. H. at least "bidentate”.
  • normally stretched compounds are closed by complex formation via an ion into rings.
  • the number of bound ligands depends on the coordination number of the central ion.
  • Customary and preferred chelate complex images in the context of the present invention are, for example, polyoxycarboxylic acids, polyamines, ethylenediaminetetraacetic acid (EDTA), nitrilotriacetic acid (NTA) and hydroxyethanediphosphonic acids or their alkali metal salts.
  • Complex-forming polymers, ie polymers which carry functional groups either in the main chain themselves or in the side thereof, which can act as ligands and generally react with suitable metal atoms to form chelate complexes can be used according to the invention.
  • the polymer-bound ligands of the resulting metal complexes can originate from only one macromolecule or belong to different polymer chains.
  • Complexing groups (ligands) of conventional complexing polymers are iminodiacetic, hydroxyquinoline, thiourea, guanidine, dithiocarbamate, hydroxamic, amidoxime, aminophosphoric, (cyclic) polyamino, mercapto, 1, 3-dicarbonyl - And crown ether residues with z. T. very specific. Activities towards ions of different metals.
  • Base polymers of many also commercially important complex-forming polymers are polystyrene, polyacrylates, polyacrylonitriles, polyvinyl alcohols, polyvinylpyridines and polyethyleneimines. Natural polymers such as cellulose, starch or chitin are also complex-forming polymers. In addition, these can be provided by polymer-analogous transformations with other ligand functionalities.
  • polycarboxylic acids a) are understood as meaning carboxylic acids, including monocarboxylic acids, in which the sum of carboxyl and the hydroxyl groups contained in the molecule is at least 5.
  • Complexing agents from the group of nitrogen-containing polycarboxylic acids, in particular EDTA are preferred.
  • these complexing agents are at least partially present as anions. It is irrelevant whether they are introduced in the form of acids or in the form of salts.
  • alkali metal, ammonium or alkylammonium salts, in particular sodium salts are preferred.
  • polymeric aminodicarboxylic acids their salts or their precursors.
  • polyaspartic acids or their salts and derivatives which, in addition to cobuilder properties, also have a bleach-stabilizing action.
  • polyacetals which can be obtained by reacting dialdehydes with polyolcarboxylic acids which have 5 to 7 C atoms and at least 3 hydroxyl groups.
  • Preferred polyacetals are obtained from dialdehydes such as glyoxal, glutaraldehyde, terephthalaldehyde and mixtures thereof and from polyol carboxylic acids such as gluconic acid and / or glucoheptonic acid.
  • phosphonates are, in particular, hydroxyalkane or aminoalkanephosphonates.
  • hydroxyalkane phosphonates 1-hydroxyethane-1,1-diphosphonate (HEDP) is of particular importance. It is preferably used as the sodium salt, the disodium salt neutral and the tetrasodium salt alkaline (pH 9).
  • Preferred aminoalkanephosphonates are ethylenediamine tetramethylenephosphonate (EDTMP), diethylenetriaminepentamethylenephosphonate (DTPMP) and their higher homologs. They are preferably in the form of neutral sodium salts, eg. B.
  • the complexing agent used here is preferably HEDP from the class of phosphonates.
  • the aminoalkanephosphonates also have a pronounced heavy metal binding capacity. Accordingly, in particular if the agents also contain bleach, it may be preferable to use aminoalkanephosphonates, in particular DTPMP, or to use mixtures of the phosphonates mentioned. These substances will be described below.
  • phosphonates preferably hydroxyalkane or aminoalkane phosphonates and in particular 1-hydroxyethane-1,1-diphosphonate (HEDP) or its di- or tetrasodium salt and / or ethylenediamine tetramethylenephosphonate (EDTMP) or its hexasodium salt and / or diethylenetriaminepentamethylenephosphonate (DTPMP ) or its hepta- or octasodium salt.
  • HEDP 1-hydroxyethane-1,1-diphosphonate
  • ETMP ethylenediamine tetramethylenephosphonate
  • DTPMP diethylenetriaminepentamethylenephosphonate
  • Particularly preferred agents according to the invention contain one or more substances from the group
  • NTA nitrilotriacetic acid
  • EDDG ethylenediamine-N-N'-diglutaric acid
  • cyclodextrins preferred agents being phosphonates, preferably hydroxyalkane or aminoalkane phosphonates and especially 1-hydroxyethane-1,1-diphosphonate (HEDP) or its di- or tetrasodium salt and / or ethylenediamine tetramethylenephosphonate (EDTMP) or its hexasodium salt and or diethylenetriaminepentamethylenephosphonate (DTPMP) or its hepta- or octasodium salt.
  • HEDP 1-hydroxyethane-1,1-diphosphonate
  • ETMP ethylenediamine tetramethylenephosphonate
  • DTPMP diethylenetriaminepentamethylenephosphonate
  • the agents according to the invention can not only be used as pure lightening agents, i. be provided as a so-called Blondierstoff, but also as a dyeing and whitening agent, which at the same time cause a coloring of the keratin fibers with the lightening.
  • such agents according to the invention contain at least one dye precursor, preferably an oxidation dye precursor and / or at least one substantive dye.
  • the agents according to the invention of this embodiment are also colorants, ie agents for changing the color of keratinic fibers. Among them, particularly the so-called oxidation colorants are preferable.
  • the oxidation colorants of the invention contain at least one coupler and at least one developer component. Coupler and developer components are also referred to as oxidation dye precursors.
  • the oxidation colorants according to the invention may also contain substantive dyes as nuances. According to preferred means for dyeing and / or lightening keratinischer fibers are therefore characterized in that they contain at least one oxidation dye precursor of the developer type and / or coupler type.
  • oxidation colorants For permanent, intensive colorations with corresponding fastness properties, so-called oxidation colorants are used. Such colorants usually contain oxidation dye precursors, so-called developer components and coupler components.
  • the developer components form the actual dyes under the influence of oxidizing agents or of atmospheric oxygen with one another or with coupling with one or more coupler components.
  • the oxidation dyes are characterized by excellent, long-lasting dyeing results. For naturally acting dyeings but usually a mixture of a larger number of oxidation dye precursors must be used; In many cases, direct dyes are still used for shading.
  • the developer components used are usually primary aromatic amines having a further, in the para or ortho position, free or substituted hydroxy or amino group, heterocyclic hydrazones, diaminopyrazole derivatives and 2,4,5,6-tetraaminopyrimidine and its derivatives.
  • coupler components m-phenylenediamine derivatives, naphthols, pyridine derivatives, resorcinol and resorcinol derivatives, pyrazolones and m-aminophenols are generally used.
  • Particularly suitable as coupler substances are 1-naphthol, 1,5-dihydroxynaphthalene, 2,7-dihydroxynaphthalene, 1,7-dihydroxynaphthalene, 5-amino-2-methylphenol, m-aminophenol, resorcinol, resorcinomonomethyl ether, m-phenylenediamine, 1-phenyl 3-methyl-pyrazol-5-one, 2,4-di-chloro-3 aminophenol, 1, 3-bis (2,4-diaminophenoxy) -propane, 2-amino-3-hydroxypyridine, 4-chlororesorcinol, 2-chloro-6-methyl-3-anninophenol, 2-methylresorcinol, 5-methylresorcino
  • dyeing or tinting agents which contain so-called direct drawers as a coloring component. These are dye molecules that attach directly to the substrate and do not require an oxidative process to form the paint. These dyes include, for example, the henna already known from antiquity for coloring body and hair. These dyeings are generally much more sensitive to shampooing than the oxidative dyeings, so that a much more rapid undesirable change in shade or even a visible, homogeneous color loss occurs much faster.
  • precursors of the natural hair dye melanin are applied to the substrate, e.g. Hair, applied; These then form naturally-analogous dyes in the course of oxidative processes in the hair.
  • multiple use of agents with 5,6-dihydroxyindoline it is possible to reproduce natural hair color to people with graying hair.
  • the dyeing can be done with atmospheric oxygen as the sole oxidant, so that no further oxidizing agent must be used.
  • the indoline can be used as the sole dye precursor.
  • satisfactory results can often only be achieved for use in persons with originally red and, in particular, dark to black hair color, by using other dye components, in particular special oxidation dye precursors.
  • a first class of oxo dye precursors are compounds having at least one reactive carbonyl group. This first class is called a component (Oxo1).
  • a second class of oxo dye precursors form CH-acidic compounds and compounds having primary or secondary amino groups or hydroxy groups, which in turn are selected from compounds of the group formed from primary or secondary aromatic amines, nitrogen-containing heterocyclic compounds and aromatic hydroxy compounds. This second class is called a component (Oxo2).
  • the aforementioned components (oxo1) and (oxo2) are generally not themselves dyes, and therefore are not in themselves suitable for coloring keratin-containing fibers. In In combination, they form dyes in a non-oxidative process called oxo dyeing. The resulting dyeings have partially color fastness on the keratin-containing fiber, which are comparable to those of the oxidation dyeing.
  • the Nuancenspektrum achievable with the gentle oxo staining is very broad and the color obtained often has an acceptable brilliance and color depth.
  • the oxo staining method can be readily combined with the oxidative staining system.
  • the dyes coloring the substrate are usually decolorized oxidatively using appropriate oxidizing agents, for example hydrogen peroxide.
  • the object of the present invention can be combined with at least one color-changing component.
  • the color-changing components in the context of the present invention are preferably selected
  • At least one oxidation dye precursor of the type of developer components and optionally additionally at least one coupler component and / or
  • p-phenylenediamine derivatives of the formula (E1) in which
  • G 1 is a hydrogen atom, a (C 1 to C 4 ) -alkyl radical, a (C 1 to C 4 ) -
  • Monohydroxyalkyl a (C 2 to C 4 ) polyhydroxyalkyl, a (C 1 to C 4 ) alkoxy (C- 1 to
  • G 2 is a hydrogen atom, a (C 1 to C 4 ) -alkyl radical, a (C 1 to C 4 ) -
  • Monohydroxyalkyl a (C 2 to C 4 ) polyhydroxyalkyl, a (C 1 to C 4 ) alkoxy (C- 1 to
  • G 3 represents a hydrogen atom, a halogen atom such as a chlorine, bromine, iodine or fluorine atom, a (C 1 to C 4 ) alkyl radical, a (C 1 to C 4 ) monohydroxyalkyl radical, a (C 2 to C 4 ) -
  • Polyhydroxyalkyl radical a (C 1 to C 4 ) -hydroxyalkoxy radical, a (C 1 to C 4 ) -
  • G 4 represents a hydrogen atom, a halogen atom or a (C 1 to C 4 ) -alkyl radical or, when G 3 and G 4 are ortho to each other, they may together form a bridging ⁇ , ⁇ -alkylenedioxo group, such as, for example, an ethylenedioxy group ,
  • Particularly preferred p-phenylenediamines of formula (E1) are selected from one or more compounds of the group formed from p-phenylenediamine, p-toluenediamine, 2-chloro-p-phenylenediamine, 2,3-dimethyl-p-phenylenediamine , 2,6-dimethyl-p-phenylenediamine, 2,6-diethyl-p-phenylenediamine, 2,5-dimethyl-p-phenylenediamine, N, N-dimethyl-p-phenylenediamine, N, N-diethyl-p-phenylenediamine , N, N-dipropyl-p-phenylenediamine, 4-amino-3-methyl- (N, N-diethyl) -aniline, N, N-bis ( ⁇ -hydroxyethyl) -p-phenylenediamine, 4-N, N Bis ( ⁇ -hydroxyethyl) amino-2-methylaniline,
  • Very particular preferred p-phenylenediamine derivatives of the formula (E1) according to the invention are selected from at least one compound of the group p-phenylenediamine, p-toluenediamine, 2- ( ⁇ -hydroxyethyl) -p-phenylenediamine, 2- ( ⁇ , ⁇ -dihydroxyethyl) - p-phenylenediamine, N, N-bis- ( ⁇ -hydroxyethyl) -p-phenylenediamine, N- (4-amino-3-methylphenyl) -N- [3- (1 H -imidazol-1-yl) propyl] amine , as well as the physiologically acceptable salts of these compounds.
  • developer component compounds which contain at least two aromatic nuclei which are substituted by amino and / or hydroxyl groups.
  • binuclear developer components which can be used in the dyeing compositions according to the invention, mention may be made in particular of the compounds corresponding to the following formula (E2) and their physiologically tolerated salts:
  • Z 1 and Z 2 independently of one another represent a hydroxyl or NH 2 radical optionally substituted by a (C 1 to C 4 ) -alkyl radical, by a (C 1 to C 4 ) -hydroxyalkyl radical and / or by a bridge Y
  • the bridging Y is an alkylene group having 1 to 14 carbon atoms, such as a linear or branched alkylene chain or an alkylene ring, which of one or more nitrogen-containing groups and / or one or more heteroatoms such as Oxygen, sulfur or nitrogen atoms may be interrupted or terminated and may be substituted by one or more hydroxyl or (C 1 to C 8 ) alkoxy, or a direct bond
  • G 5 and G 6 independently of one another represent a hydrogen or halogen atom, a (C 1 to C 4 ) -alkyl radical, a (C 1 to C 4 ) -monohydroxyalkyl radical, a (C 2 to C 4 ) -poly
  • Preferred binuclear developer components of the formula (E2) are in particular selected from at least one of the following compounds: N, N'-bis- ( ⁇ -hydroxyethyl) -N, N'-bis- (4'-aminophenyl) -1,3-diamino -propan-2-ol, N, N'-bis ( ⁇ -hydroxyethyl) -N, N'-bis (4'-aminophenyl) ethylenediamine, N, N'-bis (4'-aminophenyl) - tetramethylenediamine, N, N'-bis ( ⁇ -hydroxyethyl) -N, N'-bis (4'-aminophenyl) tetramethylenediamine, N, N'-bis (4- (methylamino) phenyl) tetramethylenediamine, N , N'-diethyl-N, N'-bis (4'-amino-3'-methylphenyl) -ethylenediamine
  • Very particularly preferred binuclear developer components of the formula (E2) are selected from N, N'-bis ( ⁇ -hydroxyethyl) -N, N'-bis (4-aminophenyl) -1,3-diamino-propan-2-ol , Bis (2-hydroxy-5-aminophenyl) -methane, 1, 3-bis (2,5-diaminophenoxy) -propan-2-ol, N, N'-bis (4-aminophenyl) -1, 4-diazacycloheptane, 1, 10-bis (2,5-diaminophenyl) -1, 4,7,10-tetraoxadecane or one of the physiologically acceptable salts of these compounds.
  • p-aminophenol derivatives of the formula (E3) it may be preferred according to the invention to use as the developer component a p-aminophenol derivative or one of its physiologically tolerable salts. Particular preference is given to p-aminophenol derivatives of the formula (E3)
  • G 13 represents a hydrogen atom, a halogen atom, a (C 1 to C 4 ) -alkyl radical, a (C 1 to C 4 ) -
  • G 14 is a hydrogen or halogen atom, a (C 1 to C 4 ) -alkyl radical, a (C 1 to C 4 ) -
  • Monohydroxyalkyl a (C 2 to C 4 ) polyhydroxyalkyl, a (C 1 to C 4 ) alkoxy (C- 1 to
  • G 15 is hydrogen, a (C 1 to C 4 ) -alkyl radical, a (C 1 to C 4 ) monohydroxyalkyl radical, a (C 2 to C 4 ) -polyhydroxyalkyl radical, a phenyl radical or a benzyl radical, and
  • G 16 is hydrogen or a halogen atom.
  • Preferred p-aminophenols of the formula (E3) are, in particular, p-aminophenol, N-methyl-p-aminophenol, 4-amino-3-methylphenol, 4-amino-3-fluorophenol, 2-hydroxymethylamino-4-aminophenol, 4 -Amino-3-hydroxymethylphenol, 4-amino-2- ( ⁇ -hydroxyethoxy) -phenol, 4-amino-2-methylphenol, 4-amino-2-hydroxymethylphenol, 4-amino-2-methoxymethyl-phenol, 4-amino -2-aminomethylphenol, 4-amino-2- ( ⁇ -hydroxyethyl-aminomethyl) phenol, 4-amino-2- ( ⁇ , ⁇ -dihydroxyethyl) phenol, 4-amino-2-fluorophenol, 4-amino-2 -chlorophenol, 4-amino-2,6-dichlorophenol, A-amino-2- (diethyl-aminomethyl) -phenol and their
  • Very particularly preferred compounds of the formula (E3) are p-aminophenol, 4-amino-3-methylphenol, 4-amino-2-aminomethylphenol, 4-amino-2- ( ⁇ , ⁇ -dihydroxyethyl) -phenol and 4-amino 2- (diethylaminomethyl) phenol.
  • the developer component may be selected from o-aminophenol and its derivatives such as 2-amino-4-methylphenol, 2-amino-5-methylphenol or 2-amino-4-chlorophenol.
  • the developer component may be selected from heterocyclic developer components, such as pyrimidine derivatives, pyrazole derivatives, pyrazolopyrimidine derivatives or their physiologically acceptable salts.
  • heterocyclic developer components such as pyrimidine derivatives, pyrazole derivatives, pyrazolopyrimidine derivatives or their physiologically acceptable salts.
  • Preferred pyrimidine derivatives are selected according to the invention from compounds of the formula (E4) or their physiologically tolerated salts,
  • G 20 represents a hydroxy group or a group -NG 21 G 22 , in which G 21 and G 22 independently of one another represent a hydrogen atom, a (C 1 to C 4 ) -alkyl group, a (C 1 to C 4 )
  • Particularly preferred pyrimidine derivatives are, in particular, the compounds 2,4,5,6-tetraaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 2-dimethylamino-4 , 5,6-triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine and 2,5,6-triaminopyrimidine.
  • Preferred pyrazole derivatives are selected according to the invention from compounds of the formula (E5),
  • G 23, G 24, G 25 are each independently a hydrogen atom, a (Ci to C 4) - alkyl, (Ci to C 4) monohydroxyalkyl, a (C 2 to C 4) -polyhydroxyalkyl group, an optionally substituted aryl group or an optionally substituted aryl (d to C 4 ) -alkyl group, with the proviso that when G 25 is a hydrogen atom, G 26 may additionally be a group -NH 2 in addition to the abovementioned groups,
  • G 26 represents a hydrogen atom, a (C 1 to C 4 ) -alkyl group, a (C 1 to C 4 ) -
  • G 27 represents a hydrogen atom, an optionally substituted aryl group, a (Ci to C 4 ) -
  • the radical -NG G binds to the 5-position and the radical G to the 3-position of the pyrazole cycle.
  • Particularly preferred pyrazole derivatives are in particular the compounds which are selected from 4,5-diamino-1-methylpyrazole, 4,5-diamino-1- ( ⁇ -hydroxyethyl) pyrazole, 3,4-diaminopyrazole, 4,5- Diamino-1- (4'-chlorobenzyl) pyrazole, 4,5-diamino-1,3-dimethylpyrazole, 4,5-diamino-3-methyl-1-phenylpyrazole, 4,5-diamino-1-methyl-3 -phenylpyrazole, 4-amino-1,3-dimethyl-5-hydrazinopyrazole, 1-benzyl-4,5-diamino-3-methylpyrazole, 4,5-diamino-3-tert-butyl-1-methylpyrazole, 4 5-diamino-1-tert-butyl-3-methylpyrazole, 4,5-diamino-1- ( ⁇ -hydroxyethy
  • Preferred pyrazolopyrimidine derivatives are, in particular, the derivatives of the pyrazolo [1,5-a] pyrimidine of the following formula (E6) and their tautomeric forms, if a tautomeric equilibrium exists:
  • G, G and G, G are independently a hydrogen atom, a (C 1 to C 4) - alkyl radical, an aryl radical, a (Ci to C 4) monohydroxyalkyl, a (C 2 to C 4) - polyhydroxyalkyl a (C 1 to C 4 ) -alkoxy- (C 1 to C 4 ) -alkyl radical, a (C 1 to C 4 ) - Aminoalkyl radical, which may be optionally protected by an acetyl ureide or a sulfonyl residue, a (C 1 to C 4) alkylamino (Ci to C4) alkyl, a di - [(d to C4) - alkyl] - (C- ⁇ to C 4 ) -aminoalkylrest, wherein the dialkyl radicals optionally form a carbon cycle or a heterocycle with 5 or 6 chain members, a (Ci to C 4 ) -Monohydroxyalkyl
  • pyrazolo [1, 5-a] pyrimidines of the above formula (E6) can be prepared as described in the literature by cyclization from an aminopyrazole or from hydrazine.
  • Very particularly preferred developer components are selected from at least one compound from the group formed from p-phenylenediamine, p-toluenediamine, 2- ( ⁇ -hydroxyethyl) -p-phenylenediamine, 2- ( ⁇ , ⁇ -dihydroxyethyl) -p phenylenediamine, N, N-bis ( ⁇ -hydroxyethyl) p-phenylenediamine, N- (4-amino-3-methylphenyl) -N- [3- (1 H -imidazol-1-yl) propyl] amine, N, N'-bis ( ⁇ -hydroxyethyl) -N, N'-bis (4-aminophenyl) -1, 3-diamino-propan-2-ol, bis (2-hydroxy-5-aminophenyl) - methane, 1,3-bis- (2,5-diaminophenoxy) -propan-2-ol, N, N'-bis (4-aminoph
  • Examples of (C 1 to C 4 ) -alkoxy radicals according to the invention are -OCH 3 , -OCH 2 CH 3 ,
  • a particularly preferred example of a (C 2 to C 4 ) polyhydroxyalkyl group is 1, 2
  • halogen atoms are F, Cl or Br atoms, Cl atoms are very particularly preferred
  • nitrogen-containing groups are in particular -NH 2 , (C 1 to C 4 ) -monoalkylamino groups,
  • Examples of (C 1 to C 4 ) -monoalkylamino groups are -NHCH 3 , -NHCH 2 CH 3 , -NHCH 2 CH 2 CH 3 ,
  • Examples of (C 1 to C 4 ) -dialkylamino groups are -N (CH 3 ) 2 , -N (CH 2 CH 3 ) 2 .
  • Examples of (C 1 to C 4 ) trialkylammonium groups are -N + (CH 3 ) 3 , -N + (CH 3 ) 2 (CH 2 CH 3 ),
  • Examples of (C 1 to C 4 ) -hydroxyalkylamino radicals are -NH-CH 2 CH 2 OH, -NH-CH 2 CH 2 OH,
  • Examples of (C 1 to C 4 ) -alkoxy- (C 1 -C 4 ) -alkyl groups are the groups -CH 2 CH 2 -O-CH 3 ,
  • hydroxy (C 1 -C 4 ) -alkoxy radicals are -O-CH 2 OH, -O-CH 2 CH 2 OH, -O-CH 2 CH 2 CH 2 OH,
  • Examples of (C 1 to C 4 ) -acetylaminoalkoxy radicals are -O-CH 2 NHC (O) CH 3 , -O-CH 2 CH 2 NHC (O) CH 3 ,
  • Examples of (C 1 to C 4 ) -aminoalkyl radicals are -CH 2 NH 2 , -CH 2 CH 2 NH 2 , -CH 2 CH 2 CH 2 NH 2 ,
  • Examples of (C 1 to C 4 ) -cyanoalkyl radicals are -CH 2 CN, -CH 2 CH 2 CN, -CH 2 CH 2 CH 2 CN.
  • Examples of (C 1 to C 4 ) -hydroxyalkylamino (C 1 to C 4 ) -alkyl radicals are -CH 2 CH 2 NH-CH 2 CH 2 OH,
  • Examples of di [(C 1 to C 4 ) -hydroxyalkyl] amino- (C 1 to C 4 ) -alkyl radicals are -CH 2 CH 2 N (CH 2 CH 2 OH) 2 ,
  • aryl groups is the phenyl group.
  • aryl (C 1 to C 4 ) alkyl groups are the benzyl group and the 2-phenylethyl group.
  • Coupler components do not form a significant color within the framework of the oxidative dyeing alone, but always require the presence of developer components. Therefore, it is preferred according to the invention that at least one coupler component is additionally used when using at least one developer component.
  • Coupler components according to the invention allow at least one substitution of a chemical residue of the coupler by the oxidized form of the developer component. This forms a covalent bond between the coupler and the developer component.
  • Couplers are preferably cyclic compounds which carry on cycle at least two groups selected from (i) optionally substituted amino groups and / or (ii) hydroxy groups. When the cyclic compound is a six-membered ring (preferably aromatic), said groups are preferably in ortho position or meta position to each other.
  • Coupler components according to the invention are preferably selected as at least one compound from one of the following classes:
  • o-aminophenol derivatives such as o-aminophenol
  • Naphthalene derivatives having at least one hydroxy group having at least one hydroxy group
  • Pyrazolone derivatives such as 1-phenyl-3-methylpyrazol-5-one,
  • Morpholine derivatives such as, for example, 6-hydroxybenzomorpholine or 6-aminobenzomorpholine,
  • m-aminophenols or derivatives thereof which can be used according to the invention are preferably selected from at least one compound of the formula (K1) and / or from at least one physiologically tolerated salt of a compound of the formula (K1),
  • G 1 and G 2 independently of one another represent a hydrogen atom, a (C 1 to C 4 ) -alkyl group, a (C 3 to C 6 ) -cycloalkyl group, a (C 2 to C 4 ) -alkenyl group, a (C 1 to C 4 ) Monohydroxyalkyl group, a (C 2 to C 4 ) polyhydroxyalkyl group, a (C 2 to C 4 ) perfluoroacyl group, an aryl (C 1 to C 6 ) alkyl group, an amino (C 1 to C 6 ) alkyl group, a (Ci to C 6 ) -Dialkylamino- (d to C 6 ) -alkyl distr or a (Ci to C 6 ) -alkoxy- (d to C 6 ) -alkyl distr, whereby G 1 and G 2 together with the nitrogen atom a five-membered can form a six-membered or seven-membered ring
  • G 3 and G 4 independently represent a hydrogen atom, a halogen atom, a (C 1 to C 4 ) alkyl group, a (C 1 to C 4 ) alkoxy group, a hydroxy group, a (C 1 to C 4 ) monohydroxyalkyl group , a (C 2 to C 4 ) polyhydroxyalkyl group, a hydroxy (C 1 -C 4 ) alkoxy group, a (C 1 to C 6 ) -alkoxy (C 2 to C 6 ) alkoxy group, an aryl group or a heteroaryl group.
  • Particularly preferred m-aminophenol coupler components are selected from at least one compound selected from the group consisting of m-aminophenol, 5-amino-2-methylphenol, N-cyclopentyl-3-aminophenol, 3-amino-2-chloro-6 methylphenol, 2-hydroxy-4-aminophenoxyethanol, 2,6-dimethyl-3-aminophenol, 3-trifluoroacetylamino-2-chloro-6-methylphenol, 5-amino-4-chloro-2 methylphenol, 5-amino-4-methoxy-2-naphthylphenol, 5- (2'-hydroxyethyl) amino-2-naphthylphenol, 3- (diethylamino) -phenol, N-cyclopentyl-3-anninophenol, 1, 3-dihydroxy -5- (methylamino) benzene, 3-ethylamino-4-naphthylphenol, 2,4-dichloro-3-aminophenol and the physiologically
  • m-diaminobenzenes or derivatives thereof which can be used according to the invention are preferably selected from at least one compound of the formula (K2) and / or from at least one physiologically tolerated salt of a compound of the formula (K2),
  • G 5, G 6, G 7 and G 8 are independently a hydrogen atom, a (Ci to C 4) - alkyl group, a (C 3 -C 6) cycloalkyl group, a (C 2 to C 4) alkenyl group, a (Ci to C 4) monohydroxyalkyl, a (C 2 to C 4) - polyhydroxyalkyl group, a (C -C 4) alkoxy (Ci -C 4) alkyl group, an aryl (d to C4) - alkyl group, a heteroaryl (d to C 4 ) alkyl group, a (C 2 to C 4 ) perfluoroacyl group, or together with the nitrogen atom form a five-membered or six-membered heterocycle
  • G 9 and G 10 independently represent a hydrogen atom, a halogen atom, a
  • (C 1 to C 4 ) -alkyl group an ⁇ - (2,4-diaminophenyl) - (d to C 4 ) -alkyl group, an ⁇ - (2,4-diaminophenyloxy) - (d to C 4 ) -alkoxy group, a (C 1 to C 4 ) alkoxy group, a hydroxy group, a (C 1 to C 4 ) alkoxy (C 2 to C 4 ) alkoxy group, an aryl group, a heteroaryl group, a (C 1 to C 4 ) - Monohydroxyalkyl group, a (C 2 to C 4 ) polyhydroxyalkyl group, a hydroxy (d to C 4 ) alkoxy group.
  • Particularly preferred m-diaminobenzene coupler components are selected from at least one compound from the group formed from m-phenylenediamine, 2- (2,4-diaminophenoxy) ethanol, 1, 3-bis (2,4-diaminophenoxy) propane, 1-Methoxy-2-amino-4- (2'-hydroxyethylamino) benzene, 1, 3-bis (2,4-diaminophenyl) propane, 2,6-bis (2'-hydroxyethylamino) -1- methylbenzene, 2 - ( ⁇ 3 - [(2-hydroxyethyl) amino] -4-n-ethoxy-5-methylphenyl ⁇ -annino) ethanol, 2 - ( ⁇ 3 - [(2-hydroxyethyl) amino] -2-methoxy-5- ethyl phenyl ⁇ -annino) ethanol, 2 - ( ⁇ 3 - [(2-hydroxyethyl) amino] -2-meth
  • o-diaminobenzenes or their derivatives which can be used according to the invention are preferably selected from at least one compound of the formula (K3) and / or from at least one physiologically tolerated salt of a compound of the formula (K3),
  • G 11, G 12, G 13 and G 14 are independently a hydrogen atom, a (Ci to C 4) - alkyl group, a (C 3 -C 6) cycloalkyl group, a (C 2 to C 4) alkenyl group, a (C 1 to C 4) monohydroxyalkyl, a (C 2 to C 4) - polyhydroxyalkyl group, a (C 1 to C 4) alkoxy alkyl (C- ⁇ -C 4), aryl (C ⁇ to C 4 ) alkyl group, a heteroaryl (C- ⁇ to C 4 ) alkyl group, a (C 2 to C 4 ) perfluoroacyl group, or together with the nitrogen atom form a five-membered or six-membered heterocycle
  • G 15 and G 16 are independently a hydrogen atom, a halogen atom, a carboxyl group, a (C 1 to C 4) alkyl group, a (C 1 to C 4) - alkoxy group, a hydroxy group, a (C 1 to C 4 ) monohydroxyalkyl, a (C 2 to C 4) -polyhydroxyalkyl group, a hydroxy (C- ⁇ -C 4) - alkoxy group.
  • Particularly preferred o-diaminobenzene coupler components are selected from at least one compound selected from the group consisting of 3,4-diaminobenzoic acid and 2,3-diamino-1-methylbenzene and the physiologically acceptable salts of all of the aforementioned compounds.
  • Preferred di- or trihydroxybenzenes and their derivatives are selected from at least one compound of the group which is formed from resorcinol, resorcinol monomethyl ether, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol, 2-chlororesorcinol, 4-chlororesorcinol, pyrogallol and 1,2,4-trihydroxybenzene.
  • the pyridine derivatives which can be used according to the invention are preferably selected from at least one compound of the formula (K4) and / or from at least one physiologically tolerable salt of a compound of the formula (K4),
  • G and G independently of one another represent a hydroxy group or a group -NG G, in which G 21 and G 22 independently of one another represent a hydrogen atom, a (C 1 to C 4 ) -alkyl group, a (C 3 to C 6 ) -cycloalkyl group , a (C 2 to C 4 ) alkenyl group, an aryl group, a (C 1 to C 4 ) monohydroxyalkyl group, a (C 2 to C 4 ) polyhydroxyalkyl group, a (C 1 to C 4 ) alkoxy (C - ⁇ to C 4 ) -alkyl group, an aryl- (C 1 -C 4 ) -alkyl group, a heteroaryl- (C 1 -C 4 ) -alkyl group,
  • G 19 and G 20 independently of one another represent a hydrogen atom, a halogen atom, a (C 1 to C 4 ) -alkyl group or a (C 1 to C 4 ) -alkoxy group.
  • radicals G 17 and G 18 are in the ortho position or in the meta position relative to one another.
  • Particularly preferred pyridine derivatives are selected from at least one compound of the group formed from 2,6-dihydroxypyridine, 2-amino-3-hydroxypyridine, 2-amino-5-chloro-3-hydroxypyridine, 3-amino-2-methylamino 6-methoxypyridine, 2,6-dihydroxy-3,4-dimethylpyridine, 2,6-dihydroxy-4-methylpyridine, 2,6-diaminopyridine, 2,3-diamino-6-methoxypyridine, 3,5-diamino-2, 6-dimethoxypyridine, 3,4-diaminopyridine, 2- (2-methoxyethyl) amino-3-amino-6-methoxypyridine, 2- (4'-methoxyphenyl) amino-3-aminopyridine, and the physiologically acceptable salts of the aforementioned compounds.
  • Preferred naphthalene derivatives having at least one hydroxy group are selected from at least one compound of the group formed from 1-naphthol, 2-methyl-1-naphthol, 2-hydroxymethyl-1-naphthol, 2-hydroxyethyl-1-naphthol, 1, 3 Dihydroxynaphthalene, 1, 5 Dihydroxynaphthalene, 1,6-dihydroxynaphthalene, 1,7-dihydroxynaphthalene, 1,8-dihydroxynaphthalene, 2,7-dihydroxynaphthalene and 2,3-dihydroxynaphthalene.
  • the indole derivatives which can be used according to the invention are preferably selected from at least one compound of the formula (K5) and / or from at least one physiologically tolerated salt of a compound of the formula (K5),
  • G 23 represents a hydrogen atom, a (C 1 to C 4 ) alkyl group, a (C 3 to C 6 ) cycloalkyl group, a (C 2 to C 4 ) alkenyl group, a (Ci to C 4 ) monohydroxyalkyl group , a (C 2 to C 4 ) -
  • G 24 represents a hydroxy group or a group -NG 26 G 27 , in which G 26 and G 27 independently of one another represent a hydrogen atom, a (C 1 to C 4 ) - Alkyl group, a (C 3 to C 6 ) -
  • Cycloalkyl group a (C 2 to C 4) alkenyl group, a (Ci to C 4) monohydroxyalkyl, a (C 2 to C 4) polyhydroxyalkyl group,
  • Hydrogen atom a halogen atom or a (Ci to C 4 ) alkyl group, with the proviso that G 24 binds in the meta position or ortho position to the structural fragment NG 23 of the formula.
  • Particularly preferred indole derivatives are selected from at least one compound of the group which is formed from 4-hydroxyindole, 6-hydroxyindole and 7-hydroxyindole and the physiologically acceptable salts of the abovementioned compounds.
  • the indoline derivatives which can be used according to the invention are preferably selected from at least one compound of the formula (K6) and / or from at least one physiologically tolerable salt of a compound of the formula (K6),
  • G 28 represents a hydrogen atom, a (C 1 to C 4) alkyl group, a (C 3 -C 6) cycloalkyl group, a (C 2 to C 4) alkenyl group, a (Ci to C 4) -monohydroxyalkyl, a (C 2 to C 4 ) -
  • G 29 represents a hydroxy group or a group -NG 31 G 32 , in which G 31 and G 32 independently of one another represent a hydrogen atom, a (C 1 to C 4 ) - Alkyl group, a (C 3 to C 6 ) -
  • Cycloalkyl group a (C 2 to C 4) alkenyl group, a (Ci to C 4) monohydroxyalkyl, a (C 2 to C 4) polyhydroxyalkyl group,
  • G 30 is a hydrogen atom, a halogen atom or a (C 1 to C 4 ) -alkyl group, with the proviso that G 29 binds in the meta position or ortho position to the structural fragment NG 28 of the formula.
  • Particularly preferred indoline derivatives are selected from at least one compound of the group formed from 4-hydroxyindoline, 6-hydroxyindoline and 7-hydroxyindoline and the physiologically acceptable salts of the aforementioned compounds.
  • Preferred pyrimidine derivatives are selected from at least one compound of the group formed from 4,6-diaminopyrimidine, 4-amino-2,6-dihydroxypyrimidine, 2,4-diamino-6-hydroxypyrimidine, 2,4,6-trihydroxypyrimidine, 2 -Amino-4-methylpyrimidine, 2-amino-4-hydroxy-6-methylpyrimidine and 4,6-dihydroxy-2-methylpyrimidine and the physiologically acceptable salts of the aforementioned compounds.
  • coupler components according to the invention are selected from m-aminophenol, 5-amino-2-methylphenol, 3-amino-2-chloro-6-methylphenol, 2-hydroxy-4-aminophenoxyethanol, 5-amino-4-chloro-2-methylphenol , 5- (2'-hydroxyethyl) amino-2-methylphenol, 2,4-dichloro-3-aminophenol, o-aminophenol, m-phenylenediamine, 2- (2,4-diaminophenoxy) ethanol, 1, 3-bis (2,4-diaminophenoxy) propane, 1-methoxy-2-amino-4- (2'-hydroxyethylamino) benzene, 1, 3-bis (2,4-diaminophenyl) propane, 2,6-bis (2'-bis) hydroxyethylamino) -1-methylbenzene, 2 - ( ⁇ 3 - [(2-hydroxyethyl) amino] -4-methoxy-5-methylphenyl ⁇ amino
  • the coupler components are preferably used in an amount of 0.005 to 20 wt .-%, preferably 0.1 to 5 wt .-%, each based on the ready-to-use oxidation colorant.
  • developer components and coupler components are generally used in approximately molar amounts to each other.
  • a certain excess of individual oxidation dye precursors is not disadvantageous, so that developer components and coupler components in a molar ratio of 1: 0.5 to 1: 3, in particular 1: 1 to 1: 2 , can stand.
  • Examples of (C 3 to C 6 ) cycloalkyl groups according to the invention are cyclopropyl, cyclopentyl and cyclohexyl.
  • Examples of (C 1 to C 4 ) -alkoxy radicals according to the invention are -OCH 3 , -OCH 2 CH 3 ,
  • a particularly preferred example of a (C 2 to C 4 ) polyhydroxyalkyl group is 1, 2
  • halogen atoms are F, Cl or Br atoms, Cl atoms are very particularly preferred
  • nitrogen-containing groups are in particular -NH 2 , (C 1 to C 4 ) -monoalkylamino groups,
  • Examples of (C 1 to C 4 ) -monoalkylamino groups are -NHCH 3 , -NHCH 2 CH 3 , -NHCH 2 CH 2 CH 3 ,
  • Examples of (C 1 to C 4 ) -dialkylamino group are -N (CH 3 ) 2 , -N (CH 2 CH 3 ) 2 .
  • Examples of (C 1 to C 4 ) -alkoxy- (C 1 -C 4 ) -alkyl groups are the groups -CH 2 CH 2 -O-CH 3 ,
  • Examples of (C 1 to C 4 ) -alkoxy (C 1 to C 4 ) -alkoxy groups are the groups -O-CH 2 CH 2 -O-CH 3 ,
  • hydroxy (C 1 to C 4 ) alkoxy radicals are -O-CH 2 OH, -O-CH 2 CH 2 OH, -O-CH 2 CH 2 CH 2 OH,
  • Examples of (C 1 to C 4 ) -aminoalkyl radicals are -CH 2 NH 2 , -CH 2 CH 2 NH 2 , -CH 2 CH 2 CH 2 NH 2 ,
  • aryl groups is the phenyl group, which may also be substituted.
  • aryl (C 1 to C 4 ) alkyl groups are the benzyl group and the 2-phenylethyl group.
  • the agents according to the invention may contain at least one substantive dye. These are dyes that raise directly on the hair and do not require an oxidative process to form the color. Direct dyes are usually nitrophenylenediamines, nitroaminophenols, azo dyes, anthraquinones or indophenols.
  • the substantive dyes are each preferably used in an amount of 0.001 to 20 wt .-%, based on the total application preparation.
  • the total amount of substantive dyes is preferably at most 20% by weight.
  • Direct dyes can be subdivided into anionic, cationic and nonionic substantive dyes.
  • Particularly suitable anionic direct dyes are 6-hydroxy-5 - [(4-sulfophenyl) azo] -2-naphthalenesulfonic acid disodium salt (CI 15.985, Food Yellow No. 3, FD & C Yellow No. 6), 2,4-dinitro-1 -naphthol-7-sulfonic acid disodium salt (Cl.10.316; Acid Yellow 1, Food Yellow No. 1), 2- (indan-1, 3-dion-2-yl) quinoline-x, x-sulfonic acid (mixture of mono and disulfonic acid) (Cl 47,005, D & C Yellow No. 10, Food Yellow No.
  • Acid Red 95 2-hydroxy-3 - ((2-hydroxynaphth-1-yl) azo) Sodium salt of 5-nitrobenzenesulfonate (Cl 15.685, Acid Red 184), 3-hydroxy 4- (3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-ylazo) -naphthalene-1-sulfonic acid sodium salt, chromium complex (Acid Red 195), 3- Hydroxy-4 - [(4-methyl-2-sulfonphenyl) azo] -2-naphthalenecarboxylic acid calcium salt (Cl.
  • Pigment Red 57 1), 3 - [(2,4-dimethyl-5-sulfophenyl) azo] -4-hydroxy-1-naphthalenesulfonic acid disodium salt (Cl 14.700; Food Red No. 1; Ponceau SX; FD & C Red No. 4), 1,4-bis [(2-sulfo-4-methylphenyl) amino] -9,10-anthraquinone disodium salt (Cl.
  • Acid Blue 1 bis [4- (diethylamino) phenyl] (5-hydroxy-2, 4-disulfophenyl) - carbenium inner salt, calcium salt (2: 1) (CI 42,051, Acid Blue 3), N - [4 - [(2,4-disulfophenyl) [4- [ethyl (phenylmethyl) amino) phenyl] ] methylene] -2,5-cyclohexadien-1-ylidene] -N-ethylbenzenemethanamine hydroxide, inner salt, sodium salt (CI 42.080, Acid Blue 7), (2-sulfophenyl) di [4- (ethyl (4- sulfophenyl) methyl) amino) phenyl] -carbenium disodium salt betaine (CI 42.090; Acid Blue 9; FD & C Bl no.
  • Preferred anionic substantive dyes are those under the international designations or trade names Acid Yellow 1, Yellow 10, Acid Yellow 23, Acid Yellow 36, Acid Orange 7, Acid Red 33, Acid Red 52, Pigment Red 57: 1, Acid Blue 7, Acid Green 50, Acid Violet 43, Acid Black 1 and Acid Black 52 known compounds.
  • Particularly suitable cationic direct dyes are 9- (dimethylannino) benzo [a] phenoxazine-7-ium chloride (Cl 51, 175, Basic Blue 6), di [4- (diethylamino) phenyl] [4- (ethylamino ) naphthyl] carbenium chloride (Cl 42,595; Basic Blue 7), di- (4- (dimethylannino) phenyl) - (4- (methylphenylamino) naphthalen-1-yl) carbenium chloride (CI 42,563; Basic Blue 8), 3,7-di (dimethylamino) -phenothiazine-5-ium chloride (CI 52.015 Basic Blue 9), di [4- (dimethylamino) phenyl] [4- (phenylamino) naphthyl] carbenium chloride ( Cl.44,045; Basic Blue 26), 2- [(4- (ethyl (2-hydroxye
  • Basic Green 1 di (4- (dimethylamino) phenyl) -phenylnethanol (Cl. 42,000, Basic Green 4), 1- (2-morpholinium-propylamino) -4-hydroxy-9,10-anthraquinone-methylsulfate, 1- [(3- (Dimethylpropylanninunn) propyl) amino] -4- (n-ethylannino) -9,10-anthraquinone chloride and substantive dyes containing a heterocycle having at least one quaternary nitrogen atom.
  • aromatic systems substituted with a quaternary nitrogen group such as Basic Yellow 57, Basic Red 76, Basic Blue 99, Basic Brown 16 and Basic Brown 17, as well as
  • Preferred cationic substantive dyes of group (c) are in particular the following compounds:
  • the compounds of the formulas (DZ1), (DZ3) and (DZ5) which are also known by the names Basic Yellow 87, Basic Orange 31 and Basic Red 51, are very particularly preferred cationic substantive dyes of group (c).
  • the cationic substantive dyes sold under the trademark Arianor are also very particularly preferred cationic substantive dyes according to the invention.
  • Nonionic substantive dyes are:
  • Suitable nonionic substantive dyes are in particular nonionic nitro and quinone dyes and neutral azo dyes.
  • Suitable blue nitro dyes are in particular:
  • Suitable red nitro dyes are in particular:
  • Suitable yellow nitro dyes are in particular:
  • 1,2-diamino-4-nitrobenzene (CI 76,020), 1 - [(2-hydroxyethyl) amino] -2-nitrobenzene (HC Yellow 2), 1- (2-hydroxyethoxy) -2 - [(2-hydroxyethyl ) amino] -5-nitrobenzene (HC Yellow 4), 1-amino-2 - [(2-hydroxyethyl) amino] -5-nitrobenzene (HC Yellow 5), 4 - [(2,3-dihydroxypropyl) amino] 3-nitro-1-trifluoromethylbenzene (HC Yellow 6), 2- [di (2-hydroxyethyl) amino] -5-nitrophenol, 2 - [(2-hydroxyethyl) amino] -1-methoxy-5- nitrobenzene, 2-amino-3-nitrophenol, 2-amino-4-nitrophenol, 1-amino-2-methyl-6-nitrobenzene, 1- (2-hydroxyethoxy) -3-methylannino-4-nitrobenzene, 2,3- (D
  • Suitable quinone dyes are in particular:
  • Suitable neutral azo dyes are in particular:
  • Preferred nonionic substantive dyes are those under the international designations or trade names HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, HC Yellow 12, HC Orange 1, Disperse Orange 3, HC Red 1, HC Red 3, HC HC Red 11, HC Red 11, HC Red 11, HC Blue 11, HC Blue 2, HC Blue 11, HC Blue 12, Disperse Blue 3, HC Violet 1, Disperse Violet 1, Disperse Violet 4, Disperse Black 9 well-known compounds, as well 1,4-diamino-2-nitrobenzene, 2-amino-4-nitrophenol, 1,4-bis (2-hydroxyethyl) amino-2-nitrobenzene, 3-nitro-4- (2-hydroxyethyl) aminophenol, 2- (2-hydroxyethyl) amino-4,6-dinitrophenol, 4 - [(2-hydroxyethyl) amino] -3-nitro-1-methylbenzene, 1-amino-4- (2-hydroxyethyl) amino-5- Chloro-2-nitrobenzene, 4-amino-3-nitrophenol
  • the substantive dyes each represent uniform compounds. Rather, due to the production process for the individual dyes, minor amounts of other components may be included, as far as they do not adversely affect the coloring result or for other reasons, e.g. toxicological, must be excluded.
  • Naturally occurring dyes can also be used as substantive dyes, such as, for example, henna red, henna neutral, henna black, chamomile blood, sandalwood, black tea, buckthorn bark, sage, bluewood, madder root, catechu, sedre and alcano root are included.
  • Preferred oxo dye precursors are a combination of at least one compound containing at least one reactive carbonyl group (component (oxo 1)) with at least one compound (component oxo2) compounds selected from (oxo2a) CH-acidic compounds and / or
  • Reactive carbonyl compounds as component (oxo1) have in the context of the invention at least one carbonyl group as a reactive group which reacts with the component (oxo2) to form a covalent bond.
  • Preferred reactive carbonyl compounds are selected from compounds which carry at least one formyl group and / or at least one keto group, in particular at least one formyl group.
  • those compounds according to the invention are also suitable as component (Oxo1) in which the reactive carbonyl group is derivatized or masked such that the reactivity of the carbon atom of the derivatized carbonyl group with respect to the component (Oxo2) is always present.
  • These derivatives are preferably addition compounds a) of amines and their derivatives to form imines or oximes as addition compound b) of alcohols to form acetals or ketals as addition compound c) of water to form hydrates as addition compound (component (Oxo1) is derived in in this case c) from an aldehyde) to the carbon atom of the carbonyl group of the reactive carbonyl compound.
  • Preferred reactive carbonyl compounds of the component (oxo1) are selected from the group consisting of benzaldehyde and its derivatives, naphthaldehyde and its derivatives, cinnamaldehyde and its derivatives, 2,3,6,7-tetrahydro-1H, 5H-benzo [ij] quinolizine-9-carboxaldehyde, 2,3,6,7-tetrahydro-8-hydroxy-1 H, 5H-benzo [ij] quinolizine-9-carboxaldehyde, N-ethylcarbazole-3-aldehyde, 2-formyln-ethylene-1,3,3-trimethylindoline (Fischers Aldehyde or tribasic aldehyde), 2-indolaldehyde, 3-indolaldehyde, 1-methylindole-3-aldehyde, 2-methylindole-3-aldehyde, 2- (1 ', 3', 3'-tri
  • Benzaldehyde and / or cinnamaldehyde and / or naphthaldehyde and / or at least one derivative of these abovementioned aldehydes, which in particular carry one or more hydroxyl, alkoxy or amino substituents, are very particularly preferably used as the reactive carbonyl component in the oxo dyeing.
  • the reactive carbonyl compound of the component (oxo1) selected from at least one compound of the formula (AC-1),
  • R 1 , R 2 and R 3 independently represent a hydrogen atom, a halogen atom, a (C 1 to C 6 ) alkyl group, a (C 2 to C 6 ) alkenyl group, a formyl group, a hydroxy group, a dC 6 Alkoxy group, a (C 1 to C 6 ) dialkylamino group, a di (C 2 -C 6 -hydroxyalkyl) amino group, a di (C 1 to C 6 ) alkoxy (C 1 to C 6 ) alkyl) amino group, a (C 1 to C 6 ) -hydroxyalkyloxy group, a sulfonyl group, a carboxyl group, a sulfonic acid group, a sulfonamide group, a carbamoyl group, a (C 2 to C 6 ) -acyl group, an acetyl group or a nitro group,
  • R 4 and R 5 represent a hydrogen atom or together form, together with the remainder of the molecule, a 5- or 6-membered aromatic or aliphatic ring.
  • the derivatives of benzaldehydes, naphthaldehydes or cinnamaldehydes of the reactive carbonyl compound according to component (Oxo1) are preferably selected from at least one compound of the group consisting of 4-hydroxy-3-methoxybenzaldehyde, 3,5-dimethoxy-4-hydroxybenzaldehyde, 4-hydroxy 1-naphthaldehyde, 4-hydroxy-2-methoxybenzaldehyde, 3,4-dihydroxy-5-methoxybenzaldehyde, 3,4,5-trihydroxybenzaldehyde, 3,5-dibromo-4-hydroxybenzaldehyde, A-hydroxy-3-nitrobenzaldehyde, 3 Bromo-4-hydroxybenzaldehyde, 4-hydroxy-3-methylbenzaldehyde, 3,5-dimethyl-4-hydroxybenzaldehyde, 5-bromo-4-hydroxy-3-methoxybenzaldehyde, 4-diethylamino-2-hydroxybenzaldehyde, 4-d
  • CH-acidic compounds are generally considered those compounds which carry a bound to an aliphatic carbon atom hydrogen atom, wherein due to electron-withdrawing substituents activation of the corresponding carbon-hydrogen bond is effected.
  • these are preferably those CH-acidic compounds which contain an aromatic and / or a heterocyclic radical.
  • the heterocyclic radical may again be aliphatic or aromatic.
  • the CH-acidic compounds are particularly preferably selected from heterocyclic compounds, in particular cationic, heterocyclic compounds.
  • component (oxo2a) at least one CH-acidic compound having an aromatic or aliphatic, heterocyclic basic body which is selected from cyclic onium compounds having the structural unit of the formula (CH-1) and / or compounds of the formula (CH-) 2)
  • R is a linear or cyclic (C 1 to C 6 ) alkyl group, a (C 2 to C 6 ) alkenyl group, an optionally substituted aryl group, an optionally substituted
  • Heteroaryl alkyl group an aryl (d-C 6) a (C 1 to C 6) hydroxyalkyl group, a
  • Ring can form and m stands for a number 2, 3, 4, 5 or 6,
  • R 7 represents a (C 1 to C 6) alkyl group, particularly a methyl group
  • X ' stands for a physiologically compatible anion
  • the cycle of the formula (CH-1) represents all ring structures, which in addition further
  • Heteroatoms such as nitrogen, oxygen or sulfur may contain and may also carry fused ring structures, all of these ring structures additional
  • Het is an optionally substituted heteroaromatic, • X 1 represents a direct bond or a carbonyl group.
  • Preferred ring structures which carry the structural unit of the formula (CH-1) are preferably selected according to the invention from 3H-indolium, benzothiazolium, benzoxazolium, 1, 2-dihydro-2-oxopyrimidiniunn, quinolinium, quinoxalinium or pyridinium.
  • compounds of the formula (CH-2) are particularly suitable for those in which the radical Het according to formula (CH-2) is derived from one of the heteroaromatic compounds furan, thiophene, pyrrole, isoxazole, isothiazole, imidazole, oxazole, thiazole, pyridine , Pyridazine, pyrimidine, pyrazine, 1, 2,3-triazine, 1, 2,4-triazine, 1, 3,5-triazine, benzopyrrole, benzofuran, benzothiophene, benzimidazole, benzoxazole, indazole, benzoisoxazole, benzoisothiazole, indole, quinoline , Isoquinoline, cinnoline, phthalazine, quinazoline, quinoxaline, acridine, benzoquinoline, benzoisoquinoline, phenazine, benzocinnoline
  • the compounds of formula (CH-2) are selected from at least one compound of the group consisting of 2- (2-furoyl) -acetonitrile, 2- (5-bromo-2-furoyl) -acetonitrile, 2- (5-methyl -2-trifluoromethyl-3-furoyl) -acetonitrile, 3- (2,5-dimethyl-3-furyl) -3-oxopropanitrile, 2- (2-thenoyl) -acetonitrile, 2- (3-thenoyl) -acetonitrile, 2- (5-Fluoro-2-thenoyl) -acetonitrile, 2- (5-chloro-2-thenoyl) -acetonitrile, 2- (5-bromo-2-thenoyl) -acetonitrile, 2- (5-methyl-2 -thenoyl) acetonitrile, 2- (2,5-dimethylpyrrol-3-oyl) -acetonit
  • the CH-acidic compounds of the oxo dye precursors of the component (oxo2a) are preferably selected from at least one compound of the formula (CH-3),
  • R 8 and R 9 are each independently a linear or cyclic (C 1 to C 6 ) - alkyl group, a (C 2 to C 6 ) alkenyl group, an optionally substituted aryl group, an optionally substituted heteroaryl group, an aryl (Ci to C 6) alkyl, a (Ci -C 6) hydroxyalkyl group, a (C 2 -C 6) -polyhydroxyalkyl group, a (Ci to C6) alkoxy (d to C6) alkyl group, a group R 'R' is N- (CH 2 ) m -, wherein R 1 and R 11 are each independently a hydrogen atom, a (C 1 to C 4 ) alkyl group, a (C 1 to C 4 ) hydroxyalkyl group or an aryl- (C i to C 4 ) -alkyl group, where R 1 and R 11 together with the nitrogen atom can form a 5-, 6- or 7-membered
  • R 10 and R 12 independently of one another represent a hydrogen atom or a C 1 -C 6 -alkyl group, where at least one of the radicals R 10 and R 12 denotes a (C 1 to C 6 ) -alkyl group,
  • R 11 represents a hydrogen atom, a (C 1 to C 6) alkyl group, a (C 1 -C 6) - hydroxyalkyl group, a (C 2 -C 6) -polyhydroxyalkyl group, a (C 1 to C 6) - Alkoxy group, a (C 1 to C 6 ) -hydroxyalkoxy group, a group R m R IV N- (CH 2 ) q -, in which R m and R IV independently of one another represent a hydrogen atom, a (C 1 to C 6 ) - hydroxyalkyl alkyl group or an aryl (C- ⁇ -C 6) and q is a number 1, 2, 3, 4, 5 or 6, wherein the radical R 11 together are - alkyl group, a (C 1 to C 6) with one of R 10 or R 12 may form a 5- or 6-membered aromatic ring optionally substituted with a halogen atom, a (C 1 to C 6 ) alkyl
  • Y represents an oxygen atom, a sulfur atom or a group NR V ", wherein R v" stands for a hydrogen atom, an aryl group, a heteroaryl group, a (C 1 to C 6) alkyl group or an aryl (C- ⁇ to C 6 ) alkyl group,
  • X ' is a physiologically acceptable anion.
  • At least one group R 10 or R 12 according to formula (CH-3) necessarily stands for a (C 1 to C 6 ) -alkyl group.
  • This alkyl group preferably carries at least two hydrogen atoms on its ⁇ -carbon atom.
  • Particularly preferred alkyl groups are the methyl, ethyl, propyl, n-butyl, iso-butyl, n-pentyl, neo-pentyl, n-hexyl group.
  • R 10 and R 12 are each independently hydrogen or a methyl group, wherein at least one group R 10 or R 12 is a methyl group.
  • Y of the formula (CH-3) is an oxygen or a sulfur atom, more preferably an oxygen atom.
  • the radical R 8 of the formula (CH-3) is preferably selected from a (C 1 to C 6 ) -alkyl group (particularly preferably a methyl group), a (C 2 to C 6 ) -alkenyl group (in particular an allyl group), a ( C 2 to C 6 ) hydroxyalkyl group (especially a 2-hydroxyethyl group) or an optionally substituted benzyl group.
  • R 11 of the formula (CH-3) is preferably a hydrogen atom.
  • radicals R 9 , R 10 and R 12 is a methyl group
  • the radical R 11 is a hydrogen atom
  • Y is an oxygen or sulfur atom
  • the radical R 8 is selected from a ( C 1 to C 6 ) alkyl group (particularly preferably a methyl group), a (C 2 to C 6 ) alkenyl group (especially an allyl group), a (C 2 to C 6 ) hydroxyalkyl group (especially a 2-hydroxyethyl group) or a optionally substituted benzyl group.
  • the compounds of formula (CH-3) are selected from one or more
  • Very particularly preferred compounds of the formula (CH-3) are selected from one or more compounds of the group of salts with physiologically acceptable counterion X ' , which is formed from salts of the formula
  • X ' in the formulas (CH-1) and (CH-3) and in the lists above preferably for halide, benzenesulfonate, p-toluenesulfonate, (Ci to C 4 ) alkanesulfonate, trifluoromethanesulfonate, perchlorate, 0.5 sulfate, hydrogen sulfate, tetrafluoroborate , Hexafluorophosphate or tetrachlorozincate.
  • the anions chloride, bromide, iodide, hydrogen sulfate or p-toluenesulfonate are preferably used as X ' .
  • the CH-acidic compounds of the oxo dye precursors of the component (oxo2a) are most preferably selected from at least one compound of the group consisting of 2- (2-furoyl) -acetonitrile, 2- (5-bromo-2-furoyl) -acetonitrile, 2- (5-Methyl-2-trifluoromethyl-3-furoyl) -acetonitrile, 3- (2,5-dimethyl-3-furyl) -3-oxopropanitrile, 2- (2-thenoyl) -acetonitrile, 2- (3 -Thenoyl) -acetonitrile, 2- (5-fluoro-2-thenoyl) -acetonitrile, 2- (5-chloro-2-thenoyl) -acetonitrile, 2- (5-bromo-2-thenoyl) -acetonitrile, 2- (5-Methyl-2-thenoyl) -acetonit
  • Trimethylquinoxaluminum p-toluenesulfonate 1-allyl-1,2-dihydro-3,4,6-trimethyl-2-oxopyrimidinium chloride, 1,2-dihydro-1- (2-hydroxyethyl) -3,4,6- trimethyl-2-oxopyrimidinium chloride, 1, 2-dihydro-1, 3,4,6-tetramethyl-2-oxopyrimidinium chloride, 1, 2-dihydro-1,3-diethyl-4,6-dimethyl 2-oxo-pyrimidinium chloride, 1, 2-dihydro-1,3-dipropyl-4,6-dimethyl-2-oxopyrimidinium chloride, 1-allyl-1,2-dihydro-3,4,6- trimethyl-2-oxopyrimidinium hydrogensulfate, 1,2-dihydro-1- (2-hydroxyethyl) -3,4,6-trimethyl-2-oxopyrimidinium hydrogensulfate, 1,2-
  • component (Oxo2b) at least one oxidation dye precursor having at least one primary or secondary amino group and / or at least one hydroxyl group can be used. Preferred suitable representatives are found under the execution of the oxidation dye precursors. However, it is preferred according to the invention if the compounds of the component (oxo2) are selected only among CH-acidic compounds.
  • the above-mentioned compounds of the component (Oxo1) and the component (Oxo2) are, when used, each preferably in an amount of 0.03 to 65 mmol, in particular from 1 to 40 mmol, based on 100 g of the total composition , used.
  • the dyestuff precursors of naturally-analogous dyes are preferably indoles and indolines which have at least two groups selected from hydroxy and / or amino groups, preferably as a substituent on the six-membered ring. These groups may carry further substituents, e.g. Example in the form of etherification or esterification of the hydroxy group or alkylation of the amino group.
  • the colorants contain at least one indole and / or indoline derivative.
  • Compositions according to the invention which comprise precursors of naturally-analogous dyes are preferably used as air-oxidative colorants. Consequently, in this embodiment said compositions are not added with an additional oxidizing agent.
  • Particularly suitable precursors of natural-analogous hair dyes are derivatives of the 5,6-dihydroxyindole of the formula (RN 1), ) in the independently
  • R 1 is hydrogen, a C 1 -C 4 -alkyl group or a C 1 -C 4 -hydroxy-alkyl group
  • R 2 is hydrogen or a -COOH group, wherein the -COOH group may also be present as a salt with a physiologically compatible cation,
  • R 3 is hydrogen or a C 1 -C 4 -alkyl group
  • R 4 is hydrogen, a C 1 -C 4 -alkyl group or a group -CO-R 6 , in which R 6 is a C 1 -C 4 -alkyl group, and
  • R 5 is one of the groups mentioned under R 4 , as well as physiologically acceptable salts of these compounds with an organic or inorganic acid.
  • indoline Particularly preferred derivatives of indoline are 5,6-dihydroxyindoline, N-methyl-5,6-dihydroxyindoline, N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline,
  • N-methyl-5,6-dihydroxyindoline N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline, N-butyl-5,6-dihydroxyindoline and especially 5, 6-Dihydroxyindolin.
  • Derivatives of 5,6-dihydroxyindoline of the formula (RN 2) are also outstandingly suitable as precursors of naturally-analogous hair dyes.
  • R 1 is hydrogen, a C 1 -C 4 -alkyl group or a C 1 -C 4 -hydroxyalkyl group
  • R 2 is hydrogen or a -COOH group, wherein the -COOH group may also be present as a salt with a physiologically compatible cation
  • R 3 is hydrogen or a C 1 -C 4 -alkyl group
  • R 4 is hydrogen, a C 1 -C 4 -alkyl group or a group -CO-R 6 , in which R 6 is a C 1 -C 4 -alkyl group, and
  • R 5 is one of the groups mentioned under R 4 , as well as physiologically acceptable salts of these compounds with an organic or inorganic acid.
  • Particularly preferred derivatives of indole are 5,6-dihydroxyindole, N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6- dihydroxyindole, 5,6-dihydroxyindole-2-carboxylic acid.
  • N-methyl-5,6-dihydroxyindole N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6-dihydroxyindole, and especially the 5,6 - Dihydroxyindole.
  • a second object of the present invention is a method for lightening
  • Keratin fibers in particular human hair, characterized in that, if desired, a pretreatment agent M1 is applied to the fiber, then an agent M2 is applied to the fiber, wherein, if desired, the agent M2 is added to the agent M2 before use, this agent M2 after is rinsed from the fiber for a period of 5-30 minutes, and after the treatment optionally a post-treatment agent M4 is applied to the fiber and rinsed after a contact time of a few minutes, wherein at least one of the agents M1, M2 or M3 or the mixture of the agents M2 and M3 is an agent according to the invention.
  • the agents according to the invention can accordingly be formulated as single-component agents (dyeing and whitening agents M2 or aftertreatment agents M4), as two-component agents (M2 + M3) or as three-component agents (M2 + M3 + M4) and used accordingly. Separation into multicomponent systems is particularly suitable where incompatibilities of the ingredients are to be expected or feared; the agent to be used in such systems is manufactured by the consumer just prior to use by mixing the component. A dyeing and whitening process in which the whitening cream and the oxidizing agent are initially separate is preferred.
  • a further subject of the present invention is therefore a process for dyeing and lightening human hair, in which an aqueous-based composition containing hydrogen peroxide is mixed with an agent according to the invention to form a homogeneous composition and applied to the hair.
  • the aqueous composition contains from 1 to 20% by weight, preferably from 2 to 10% by weight and in particular from 3 to 6% by weight of hydrogen peroxide, calculated as 100% H 2 O 2 .
  • a further subject matter of the present invention is therefore a process for dyeing and lightening human hair which comprises an aqueous-based composition containing hydrogen peroxide with a further agent containing preferably at least one alkalinity donor and / or substantive hair dye and / or at least one oxidation dye precursor, and a composition containing the compound (s) of formulas (I) and (II) mixed to form a homogeneous composition and applied to the hair.
  • Toluolsulfonkladisher stirred for 20 hours in 70 ml of toluene at room temperature. The precipitated white crystals after this period were filtered off and dried.
  • bleaching creams were prepared as follows:
  • Stabylene ® 30 acrylic acid / vinyl ester copolymer (INCI name:
  • Cetiol ® OE dioctyl ether (INCI name: dicaprylyl ether) (Cognis)
  • Turpinal ® SL 1-hydroxyethane-1, 1-diphosphonic acid (approximately 58-61% active substance content; INCI name: Etidronic Acid, Aqua (Water)) (Solutia)
  • Gluadin ® W40 wheat protein hydrolyzate (at least 40% solids, INCI name: Aqua (Water), Hydrolyzed Wheat Protein, Sodium Benzoate, Phenoxyethanol, Methylparaben, Propylparaben) (Cognis) Stabylen ® 30 and Cetiol OE were pre-dispersed at room temperature. Subsequently, the other components were incorporated with stirring in order, then made up to 100% with water.
  • formulations V1, V2 and V3 are comparison formulations which are not according to the invention, formulation E is the example according to the invention.
  • Each bleaching cream was blended in a ratio of 1: 1 with a developer dispersion composed as follows.
  • the pH of the finished application mixture was between 9 and 10.
  • Texapon ® NSO lauryl ether sulfate, sodium salt (ca. 27.5% active substance; INCI name: Sodium Laureth Sulfate) (Cognis)
  • Aculyn ® 33 acrylic polymer (about 28% solids in water; INCI name: Acrylates Copolymer)
  • Blondierprozeß was on strands of dark blond, light brown and dark brown hair (codes: Kerling 7/0, Fischbach & Miller 6923 and Kerling 7/0) of about 0.5 g weight 4 times the amount of the finished application mixture (2 g per Tress) applied. After the strands were bleached for 30 minutes at 32 0 C, they were washed with a commercial shampoo and dried with a hair dryer. Evaluation of the brightening power

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des agents puissants et peu irritants destinés à l'éclaircissement des fibres kératiniques, en particulier des cheveux humains, renfermant respectivement, par rapport à leur poids, 0,1 - 4,9 % en poids d'au moins un dérivé d'oxopipéridinium de structure générale (1), et 0,1 à 4,0 % en poids d'au moins un composé imidazole selon la formule (II) et/ou leurs sels physiologiquement compatibles, et 0,1 - 12,0% en poids de peroxyde d'hydrogène (calculé sous forme de H<SUB>2</SUB>O<SUB>2</SUB> à100%).
EP07847729A 2007-02-08 2007-12-04 Agents d'éclaircissement contenant une ou plusieurs pipéridones et imidazoles Withdrawn EP2081543A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE200710007050 DE102007007050A1 (de) 2007-02-08 2007-02-08 Aufhellmittel und Piperidon(en) und Imidazol(en)
PCT/EP2007/063220 WO2008095558A2 (fr) 2007-02-08 2007-12-04 Agents d'éclaircissement contenant une ou plusieurs pipéridones et imidazoles

Publications (1)

Publication Number Publication Date
EP2081543A2 true EP2081543A2 (fr) 2009-07-29

Family

ID=39597629

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07847729A Withdrawn EP2081543A2 (fr) 2007-02-08 2007-12-04 Agents d'éclaircissement contenant une ou plusieurs pipéridones et imidazoles

Country Status (3)

Country Link
EP (1) EP2081543A2 (fr)
DE (1) DE102007007050A1 (fr)
WO (1) WO2008095558A2 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1685997A (en) * 1995-12-28 1997-07-28 Colgate-Palmolive Company, The Peroxygen bleach composition activated by oxo-piperidinium salts
FR2785183B1 (fr) 1998-11-04 2002-04-05 Oreal COMPOSITION TINCTORIALE CONTENANT UN COLORANT DIRECT CATIONIQUE ET UNE PYRAZOLO-[1,5-a]- PYRIMIDINE A TITRE DE BASE D'OXYDATION, ET PROCEDES DE TEINTURE
DE102004028599A1 (de) * 2004-06-12 2005-12-29 Henkel Kgaa Milde Bleichmittel mit erhöhter Aufhellleistung
DE102006017837A1 (de) * 2006-04-13 2007-10-18 Henkel Kgaa Aufhellmittel mit Piperidonen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2008095558A3 *

Also Published As

Publication number Publication date
WO2008095558A3 (fr) 2009-05-22
DE102007007050A1 (de) 2008-08-14
WO2008095558A2 (fr) 2008-08-14

Similar Documents

Publication Publication Date Title
DE102008024030A1 (de) Aufhellmittel mit kationischen 3,4-Dihydroisochinoliniumderivaten, speziellen Alkanolaminen und Wasserstoffperoxid
WO2009043613A1 (fr) Agent éclaircissant contenant des dérivés cationiques de 3,4-dihydroisoquinoléinium et du peroxyde d&#39;hydrogène
DE102007047685A1 (de) Aufhellmittel mit kationischen Acylpyridiniumderivaten, Imidazolderivaten und Wasserstoffperoxid
DE102010030434A1 (de) Kationische Direktzieher mit Dimethyl[(2-oxo-1,3-dioxolan-4-yl)methyl]-ammonium-Gruppierung und Mittel zum Färben von keratinhaltigen Fasern
DE102008022710A1 (de) Aufhellmittel mit kationischen Acylpyridiniumderivaten, Co-Bleichaktivatoren und Wasserstoffperoxid
DE102008044715A1 (de) Kationische Acylpyridinium-Derivate als Bleichaktivatoren
EP2014275A2 (fr) Kit de préparation de formulations stables au stockage
DE102008052618A1 (de) Tricyclische Aldehyde und C,H-acide Verbindungen
DE102008044714A1 (de) Kationische Dihydroisochinolinium-Derivate als Bleichaktivatoren
EP1985282A2 (fr) Procédé de coloration ayant une durée d&#39;application raccourcie
DE102008036535A1 (de) Coloration mit kationisierbaren Polymer
DE102009001039A1 (de) Kationische Direktzieher und Mittel zum Färben von keratinhaltigen Fasern
WO2009019048A2 (fr) Teinture pour cheveux
DE102008018132A1 (de) Kationische Direktzieher und Mittel zum Färben von keratinhaltigen Fasern
DE102010031243A1 (de) Polycyclische Cumarinderivate mit kationischer Ladung und Mittel zum Färben von keratinhaltigen Fasern
EP1944010B1 (fr) Matériau d&#39;éclaircissement et/ou de coloration à dérivé(s) d&#39;acide(s) d&#39;acryle(s)
DE102008034845A1 (de) Färbemittel mit Wirkstoffkomplex, enthaltend Thiolactat, zur Verringerung der Haarstrukturschädigung
EP2044977B1 (fr) Procédé de coloration des cheveux avec prétraitement oxydatif
DE102009001687A1 (de) Kationische Direktzieher und Mittel zum Färben von keratinhaltigen Fasern
DE102007018380A1 (de) Kationische Direktzieher und Mittel zum Färben von keratinhaltigen Fasern
DE102008056811A1 (de) Neue Oxidationsfarbstoffvorprodukte
EP2190402A1 (fr) Biotine et acide silicique contre le vieillissement capillaire
DE102008061863A1 (de) Verfahren zur Kaschierung grauer Haare
DE102010038404A1 (de) Neuartige Anthrachinonfarbstoffe und Mittel zum Färben von keratinhaltigen Fasern
EP2081543A2 (fr) Agents d&#39;éclaircissement contenant une ou plusieurs pipéridones et imidazoles

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090324

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: KNUEBEL, GEORG

Inventor name: GROSS, WIBKE

Inventor name: FUHR, DENISE

Inventor name: NEMITZ, RALPH

Inventor name: PAULI, KRISTIN

RIN1 Information on inventor provided before grant (corrected)

Inventor name: KNUEBEL, GEORG

Inventor name: PAULI, KRISTIN

Inventor name: FUHR, DENISE

Inventor name: GROSS, WIBKE

Inventor name: NEMITZ, RALPH

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20100712

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20101123